<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T11:28:57Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:4170674" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:4170674</identifier>
        <datestamp>2014-09-22</datestamp>
        <setSpec>jimmunol</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">J Immunol</journal-id>
              <journal-id journal-id-type="iso-abbrev">J. Immunol</journal-id>
              <journal-id journal-id-type="hwp">jimmunol</journal-id>
              <journal-id journal-id-type="pmc">jimmunol</journal-id>
              <journal-id journal-id-type="publisher-id">JI</journal-id>
              <journal-title-group>
                <journal-title>The Journal of Immunology Author Choice</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0022-1767</issn>
              <issn pub-type="epub">1550-6606</issn>
              <publisher>
                <publisher-name>AAI</publisher-name>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC4170674</article-id>
              <article-id pub-id-type="pmcid">PMC4170674</article-id>
              <article-id pub-id-type="pmc-uid">4170674</article-id>
              <article-id pub-id-type="pmid">25172490</article-id>
              <article-id pub-id-type="pmid">25172490</article-id>
              <article-id pub-id-type="publisher-id">ji_1401413</article-id>
              <article-id pub-id-type="doi">10.4049/jimmunol.1401413</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Innate Immunity and Inflammation</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>TLR-Mediated Inflammatory Responses to <italic>Streptococcus pneumoniae</italic> Are Highly Dependent on Surface Expression of Bacterial Lipoproteins</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tomlinson</surname>
                    <given-names>Gillian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Chimalapati</surname>
                    <given-names>Suneeta</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pollard</surname>
                    <given-names>Tracey</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Lapp</surname>
                    <given-names>Thabo</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                  <xref ref-type="author-notes" rid="afn1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Cohen</surname>
                    <given-names>Jonathan</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                  <xref ref-type="aff" rid="aff3">‡</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Camberlein</surname>
                    <given-names>Emilie</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                  <xref ref-type="author-notes" rid="afn2">2</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Stafford</surname>
                    <given-names>Sian</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Periselneris</surname>
                    <given-names>Jimstan</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Aldridge</surname>
                    <given-names>Christine</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">§</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Vollmer</surname>
                    <given-names>Waldemar</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff4">§</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Picard</surname>
                    <given-names>Capucine</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">¶</xref>
                  <xref ref-type="aff" rid="aff6">‖</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Casanova</surname>
                    <given-names>Jean-Laurent</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff5">¶</xref>
                  <xref ref-type="aff" rid="aff7">#</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Noursadeghi</surname>
                    <given-names>Mahdad</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff1">*</xref>
                  <xref ref-type="author-notes" rid="afn3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <name>
                    <surname>Brown</surname>
                    <given-names>Jeremy</given-names>
                  </name>
                  <xref ref-type="aff" rid="aff2">†</xref>
                  <xref ref-type="author-notes" rid="afn3">3</xref>
                </contrib>
                <aff id="aff1"><label>*</label>Division of Infection and Immunity, University College London, London WC1E 6BT, United Kingdom;</aff>
                <aff id="aff2"><label>†</label>Centre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, Rayne Institute, London WC1E 6JF, United Kingdom;</aff>
                <aff id="aff3"><label>‡</label>Infectious Diseases and Microbiology Unit, University College London Institute of Child Health, London WC1N 1Eh, United Kingdom;</aff>
                <aff id="aff4"><label>§</label>Centre for Bacterial Cell Biology, Newcastle University Medical School, Newcastle upon Tyne NE2 4AX, United Kingdom;</aff>
                <aff id="aff5"><label>¶</label>Laboratory of Human Genetics of Infectious Diseases, Necker Branch, INSERM U980, Necker Medical School, University Paris Descartes, Sorbonne Paris Cité, Paris 75015, France;</aff>
                <aff id="aff6"><label>‖</label>Study Center for Primary Immunodeficiencies, Public Assistance-Paris Hospitals, Necker Enfants Malades Hospital, Paris 75743, France; and</aff>
                <aff id="aff7"><label>#</label>St. Giles Laboratory of Human Genetics of Infectious Diseases, Rockefeller Branch, The Rockefeller University, New York, NY 10065</aff>
              </contrib-group>
              <author-notes>
                <fn id="afn1" fn-type="present-address">
                  <label>1</label>
                  <p>Current address: Department of Ophthalmology, Freiburg University, Freiburg, Germany.</p>
                </fn>
                <fn id="afn2" fn-type="present-address">
                  <label>2</label>
                  <p>Current address: Faculté de Sciences et des Techniques, Nantes University, Nantes, France.</p>
                </fn>
                <fn id="afn3">
                  <label>3</label>
                  <p>M.N. and J.B. are joint senior authors.</p>
                </fn>
                <corresp id="cor1">Address correspondence and reprint requests to Prof. Jeremy Brown, Centre for Inflammation and Tissue Repair, Division of Medicine, University College Medical School, Rayne Institute, 5 University Street, London WC1E 6JF, U.K. E-mail address: <email>jeremy.brown@ucl.ac.uk</email></corresp>
              </author-notes>
              <pub-date pub-type="ppub">
                <day>1</day>
                <month>10</month>
                <year>2014</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>8</month>
                <year>2014</year>
              </pub-date>
              <volume>193</volume>
              <issue>7</issue>
              <fpage>3736</fpage>
              <lpage>3745</lpage>
              <history>
                <date date-type="received">
                  <day>03</day>
                  <month>6</month>
                  <year>2014</year>
                </date>
                <date date-type="accepted">
                  <day>04</day>
                  <month>8</month>
                  <year>2014</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2014 The Authors</copyright-statement>
                <copyright-year>2014</copyright-year>
                <copyright-holder>Copyright © 2014 The Authors</copyright-holder>
                <license license-type="creative-commons">
                  <license-p>This is an open-access article distributed under the terms of the <underline><ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">CC-BY 3.0 Unported license</ext-link></underline>.</license-p>
                </license>
              </permissions>
              <abstract>
                <p><italic>Streptococcus pneumoniae</italic> infections induce inflammatory responses that contribute toward both disease pathogenesis and immunity, but the host–pathogen interactions that mediate these effects are poorly defined. We used the surface lipoprotein-deficient ∆<italic>lgt</italic> pneumococcal mutant strain to test the hypothesis that lipoproteins are key determinants of TLR-mediated immune responses to <italic>S. pneumoniae</italic>. We show using reporter assays that TLR2 signaling is dependent on pneumococcal lipoproteins, and that macrophage NF-κB activation and TNF-α release were reduced in response to the ∆<italic>lgt</italic> strain. Differences in TNF-α responses between <italic>Δlgt</italic> and wild-type bacteria were abrogated for macrophages from TLR2- but not TLR4-deficient mice. Transcriptional profiling of human macrophages revealed attenuated TLR2-associated responses to <italic>∆lgt S. pneumoniae</italic>, comprising many NF-κB–regulated proinflammatory cytokine and chemokine genes. Importantly, non-TLR2–associated responses were preserved. Experiments using leukocytes from IL-1R–associated kinase-4–deficient patients and a mouse pneumonia model confirmed that proinflammatory responses were lipoprotein dependent. Our data suggest that leukocyte responses to bacterial lipoproteins are required for TLR2- and IL-1R–associated kinase-4–mediated inflammatory responses to <italic>S. pneumoniae</italic>.</p>
              </abstract>
              <counts>
                <page-count count="10"/>
              </counts>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>Introduction</title>
              <p><italic>Streptococcus pneumoniae</italic> pneumonia, meningitis, and septicaemia are major causes of morbidity and mortality, responsible for &gt;800,000 childhood deaths per year (<xref rid="r1" ref-type="bibr">1</xref>). <italic>S. pneumoniae</italic> infections are characteristically associated with inflammation (<xref rid="r2" ref-type="bibr">2</xref>), including a strong acute-phase response, rapid leukocyte recruitment to the site of infection, and compromise of endothelial or epithelial barriers. Although the inflammatory response is required for host immunity, excessive inflammation contributes toward serious complications of <italic>S. pneumoniae</italic> infection, such as neurologic damage, septic shock, and acute lung injury (<xref rid="r3" ref-type="bibr">3</xref>, <xref rid="r4" ref-type="bibr">4</xref>). Characterizing the factors that drive the inflammatory response to <italic>S. pneumoniae</italic> will help explain the pathogenesis of pneumococcal infections and identify targets for novel therapies.</p>
              <p>TLR are a key mechanism for innate immune sensing and are important for the host response to <italic>S. pneumoniae</italic>. Genetic deficiency of TLR signaling pathway proteins substantially increases the risk of invasive <italic>S. pneumoniae</italic> infections (<xref rid="r5" ref-type="bibr">5</xref>–<xref rid="r7" ref-type="bibr">7</xref>). Fifty-four percent of children with IL-1R–associated kinase 4 (IRAK-4) deficiency and 41% of patients with MyD88 deficiency have at least one episode of invasive pneumococcal disease (<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r8" ref-type="bibr">8</xref>–<xref rid="r10" ref-type="bibr">10</xref>). Similarly, mice deficient in the TLR-signaling molecule MyD88 are highly susceptible to <italic>S. pneumoniae</italic> infections (<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r12" ref-type="bibr">12</xref>). IRAK-4 deficiency largely prevents inflammatory responses to purified TLR ligands (<xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r7" ref-type="bibr">7</xref>), including expression of the cytokines TNF-α, IL-1β, and IL-6 that are important for host immunity to <italic>S. pneumoniae</italic> (<xref rid="r13" ref-type="bibr">13</xref>–<xref rid="r15" ref-type="bibr">15</xref>). Although innate immune recognition of <italic>S. pneumoniae</italic> is dependent on contributions from several TLRs, including TLR2, TLR4, and TLR9 (<xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r16" ref-type="bibr">16</xref>–<xref rid="r24" ref-type="bibr">24</xref>), the release of inflammatory cytokines such as TNF-α and IL-6 seems to be particularly dependent on TLR2 (<xref rid="r19" ref-type="bibr">19</xref>–<xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r25" ref-type="bibr">25</xref>). TLR2 contributes to the inflammatory response and control of infection in mouse models of meningitis and pneumonia (<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r22" ref-type="bibr">22</xref>–<xref rid="r24" ref-type="bibr">24</xref>) and has additional effects that may affect disease development. First, the proinflammatory effects of TLR4 activation and of the <italic>S. pneumoniae</italic> toxin pneumolysin are partly dependent on synergistic activation of TLR2 (<xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r27" ref-type="bibr">27</xref>). Second, adaptive immune responses to <italic>S. pneumoniae</italic> can be impaired in TLR2-deficient mice (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r29" ref-type="bibr">29</xref>). Third, TLR2-mediated respiratory epithelium responses to infection by <italic>S. pneumoniae</italic> increase tight junction breakdown and bacterial translocation across epithelial layers (<xref rid="r30" ref-type="bibr">30</xref>). Hence, identifying the <italic>S. pneumoniae</italic> TLR2 ligands is necessary for understanding of the molecular mechanisms contributing to disease pathogenesis by this pathogen.</p>
              <p>Known TLR2 ligands include peptidoglycan (PGN) and lipoteichoic acid (LTA), both components of the Gram-positive cell wall (<xref rid="r31" ref-type="bibr">31</xref>, <xref rid="r32" ref-type="bibr">32</xref>). The <italic>S. pneumoniae</italic> cell wall is highly proinflammatory, suggesting PGN and LTA could be major TLR2 agonists (<xref rid="r33" ref-type="bibr">33</xref>–<xref rid="r35" ref-type="bibr">35</xref>). However, cell wall–dependent inflammation is also mediated by NOD recognition of PGN (<xref rid="r36" ref-type="bibr">36</xref>, <xref rid="r37" ref-type="bibr">37</xref>), and purified <italic>S. pneumoniae</italic> LTA does not stimulate IL-8 production by HEK293 cells transfected with TLR2 (<xref rid="r38" ref-type="bibr">38</xref>). Hence, cell wall products may not be dominant TLR2 agonists for <italic>S. pneumoniae</italic>. Bacterial lipoproteins are important TLR2 ligands for other Gram-positive pathogens (<xref rid="r32" ref-type="bibr">32</xref>, <xref rid="r39" ref-type="bibr">39</xref>, <xref rid="r40" ref-type="bibr">40</xref>), and <italic>S. pneumoniae</italic> expresses a large number of lipoproteins, many of which are important for bacterial virulence (<xref rid="r41" ref-type="bibr">41</xref>–<xref rid="r46" ref-type="bibr">46</xref>). However, the importance of <italic>S. pneumoniae</italic> lipoproteins for TLR2-mediated immune recognition and proinflammatory responses has not been investigated. We have used a <italic>S. pneumoniae</italic> mutant strain with markedly reduced surface lipoprotein content due to deletion of the lipoprotein diacylglyceryl transferase gene <italic>lgt</italic> (<xref rid="r45" ref-type="bibr">45</xref>) to assess the contribution of lipoproteins to TLR-dependent inflammatory responses to <italic>S. pneumoniae</italic>. The effects of lipoproteins on macrophage responses to <italic>S. pneumoniae</italic> were characterized in detail using transcriptome analysis and by measuring important proinflammatory cytokine responses of mouse macrophages with deletions affecting the TLR pathway and leukocytes from patients with IRAK-4 deficiency.</p>
            </sec>
            <sec sec-type="materials|methods" id="s2">
              <title>Materials and Methods</title>
              <sec id="s3">
                <title>Ethics statement</title>
                <p>Experiments using human cells were approved by the joint University College London/University College Hospitals National Health Service Trust Human Research Ethics Committee, and written informed consent was obtained from all participants. All animal experiments were approved by the University College London Biological Services Ethical Committee and the United Kingdom Home Office (Project License PPL70/6510) and performed according to United Kingdom national guidelines for animal use and care.</p>
              </sec>
              <sec id="s4">
                <title>Bacterial strains and growth conditions</title>
                <p>The <italic>S. pneumoniae</italic> strain, TIGR4, was a gift of J. Weiser (University of Pennsylvania, Philadelphia, PA). The <italic>∆lgt</italic> strains were obtained by in-frame deletion of <italic>lgt</italic> (Sp1412) from wild-type (WT) TIGR4, D39, and <italic>∆pab</italic> TIGR4 strains, as previously described (<xref rid="r45" ref-type="bibr">45</xref>, <xref rid="r47" ref-type="bibr">47</xref>). Mutant strains were genome sequenced by the Wellcome Trust Centre for Human Genetics (Oxford, U.K.) using an Illumina MiSeq sequencer. Sequences were assembled using Velvet, annotated using Prokka, and mapped to the published TIGR4 and D39 (R00000036) reference genomes. Bases and single-nucleotide variants were identified using the SAMtools “mpileup” command and BCFtools. Sites were filtered to a minimum depth of five reads at each and single-nucleotide variant quality of 25, and the Integrated Genome Viewer was used to visualize mapping and coverage. <italic>S. pneumoniae</italic> was cultured overnight at 37°C in 5% CO<sub>2</sub> on Columbia agar (Oxoid) supplemented with 5% horse blood (TCS Biosciences). Working stocks grown to an OD of 0.4 (∼10<sup>8</sup> CFU/ml) were made using Todd-Hewitt broth supplemented with 0.5% yeast extract and stored at −80°C in 10% glycerol as single-use aliquots. CFU were confirmed by colony counting of log<sub>10</sub> serial dilutions of bacteria cultured overnight on 5% Columbia blood agar. Chloramphenicol (10 μg ml<sup>−1</sup>) and kanamycin (500 μg ml<sup>−1</sup>) were added to blood agar plates where appropriate.</p>
              </sec>
              <sec id="s5">
                <title>Preparation of bacterial lysates and Triton X-114 extraction of lipoproteins</title>
                <p>Bacterial lysates were made using mid log-phase growth <italic>S. pneumoniae</italic> cells by addition of 0.1% deoxycholate (Sigma-Aldrich) in PBS for 30 min at 37°C and sonication with a Soniprep 150 (Sanyo) ultrasonicator. Membrane-associated proteins were extracted from lysates by Triton X-114 extraction, as described previously (<xref rid="r48" ref-type="bibr">48</xref>, <xref rid="r49" ref-type="bibr">49</xref>), washed, and diluted 1:2 in PBS prior to solubilization in Laemmli sample buffer for SDS-PAGE and visualization using Coomassie brilliant blue (Sigma-Aldrich) staining.</p>
              </sec>
              <sec id="s6">
                <title>Cell isolation and culture</title>
                <p>Blood samples were obtained from healthy volunteers or IRAK-4–deficient subjects homozygous for the Q293X mutation for isolation of PBMC or production of monocyte-derived macrophage (MDM) by differentiation with M-CSF, as previously described (<xref rid="r50" ref-type="bibr">50</xref>). Bone marrow was extracted from 6- to 8-wk-old C57BL/6 WT, <italic>TLR2</italic><sup>−/−</sup>, <italic>TLR4</italic><sup>−/−</sup> (Jackson ImmunoResearch Laboratories), or <italic>Myd88/trif</italic><sup>−/−</sup> mice (gift of S. Akira, Department of Host Defense, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan) and differentiated into bone marrow–derived macrophages (BMDM) for 7 d in L929-conditioned medium using standard protocols (<xref rid="r51" ref-type="bibr">51</xref>, <xref rid="r52" ref-type="bibr">52</xref>). The RAW 264.7 murine macrophage cell line was cultured as adherent cells in RPMI 1640 (Life Technologies) supplemented with 2 mM <sc>l</sc>-glutamine (Invitrogen) and 10% FBS (Life Technologies).</p>
              </sec>
              <sec id="s7">
                <title>PGN purification and structural analysis</title>
                <p>Pneumococcal cell wall (PGN–teichoic acid complex) and PGN were prepared, as described (<xref rid="r53" ref-type="bibr">53</xref>), and muropeptide was released by digesting PGN with cellosyl (provided by Hoechst). Muropeptides were reduced with sodium borodydride and analyzed by high-pressure liquid chromatography, as described (<xref rid="r53" ref-type="bibr">53</xref>). The peaks were assigned by comparing their retention time with the retention time of known muropeptides obtained from strain R6, whose muropeptide profile is similar to that of strain TIGR4. Peak 1 (<xref ref-type="fig" rid="fig03">Fig. 3</xref>) was collected and analyzed by electrospray mass spectrometry, as described (<xref rid="r53" ref-type="bibr">53</xref>, <xref rid="r54" ref-type="bibr">54</xref>).</p>
              </sec>
              <sec id="s8">
                <title>Innate immune stimulation, cytokine measurements, and NF-κB nuclear translocation</title>
                <p>HEK TLR2 reporter assays were stimulated with <italic>S. pneumoniae</italic> for 16 h, according to the manufacturer’s instructions (Invivogen). White cells were stimulated as follows for collection of supernatants, RNA isolation, or NF-κB translocation assays: MDM and PBMC stimulated for 1–24 h with <italic>S. pneumoniae</italic> strains at a multiplicity of infection (MOI) of 5–50 or Pam<sub>2</sub>CSK<sub>4</sub> (100 ng/ml; Axis-Shield); RAW 264.7 cells stimulated with different <italic>S. pneumoniae</italic> strains at a MOI of 5 or 10 μl (in a total volume of 300 μl) Triton X-114 extracts for up to 4 h (<xref rid="r47" ref-type="bibr">47</xref>); BMDM stimulated with <italic>S. pneumoniae</italic> bacterial strains in DMEM without any supplements for 4 h at a MOI of 5. Cytokine levels were measured in cell culture supernatants using ELISA (R&amp;D Systems or eBioscience), or the Luminex or MSD platforms, according to the manufacturer’s instructions. NF-κB activation was assessed by quantifying nuclear RelA using the MSD system, according to the manufacturer’s instructions, or using immunofluorescence of MDMs to obtain nuclear:cytoplasmic ratios of NF-κB Rel A (p65) staining as a marker of NF-κB nuclear translocation (<xref rid="r50" ref-type="bibr">50</xref>, <xref rid="r55" ref-type="bibr">55</xref>).</p>
              </sec>
              <sec id="s9">
                <title>Transcriptional profiling by cDNA microarray and quantitative PCR</title>
                <p>Total RNA was purified from cell lysates using the RNEasy mini kit (Qiagen). Samples were processed for Agilent microarrays, and data were normalized, as previously described (<xref rid="r56" ref-type="bibr">56</xref>). Microarray data are available in the ArrayExpress database (<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/arrayexpress">www.ebi.ac.uk/arrayexpress</ext-link>) under accession number E-MTAB-1541. For quantitative PCR (qPCR), cDNA was synthesized using the qScript cDNA Supermix kit (Quanta BioSciences), and qPCR of selected genes was performed using the following inventoried TaqMan assays (Applied Biosystems): <italic>IL23</italic> (Hs00372324_m1), <italic>IL1β</italic> (Hs01555410_m1), <italic>IL6</italic> (Hs00985639_m1), and <italic>TNFα</italic> (Hs00174128_m1). <italic>PTSG2</italic> expression was quantified using the following: forward primer, 5′-CGGTCCTGGCGCTCAG-3′; reverse primer, 5′-CCGGGTACAATCGCACTTATACTG-3′; and probe, 5′-CCATACAGCAAATCCTT-3′ (Applied Biosystems). Expression levels of target genes were normalized to <italic>GAPDH</italic>, as previously described (<xref rid="r57" ref-type="bibr">57</xref>).</p>
              </sec>
              <sec id="s10">
                <title>Animal model of lung infection</title>
                <p>Six- to 8-wk-old outbred CD1 female white mice (Charles Rivers Breeders) were inoculated intranasally with 1 × 10<sup>7</sup> CFU in an inoculum volume of 50 μl under halothane (Zeneca) general anesthesia. Bronchoalveolar lavage fluid (BALF) samples were obtained from culled mice 4 h postinfection for cytokine assays using ELISAs (R&amp;D Systems), bacterial CFU by colony counting of serial dilutions plated onto Columbia blood agar plates containing 5 μg ml<sup>−1</sup> gentamicin, and total cell counts using a manual hemocytometer (Gova Glasstic slides; Hycor Biomedical UK) under light microscopy (original magnification ×20) following 1:2 dilution of BALF in 0.001% crystal violet in acetic acid.</p>
              </sec>
              <sec id="s11">
                <title>Statistical analysis</title>
                <p>Data that would be normally distributed (results of macrophage cytokine analyses and qPCR) were analyzed using paired (for data obtained from matched samples) or unpaired (for data obtained from unmatched samples) <italic>t</italic> tests. Nonnormally distributed data (data from mouse experiments and NF-κB nuclear translocation data) were compared using the Mann–Whitney <italic>U</italic> test. Principal component (PC) analysis was used to compare global gene expression profiles, as previously described, and <italic>t</italic> tests were used to identify significant gene expression differences (<italic>p</italic> &lt; 0.05) between samples using MultiExperiment Viewer v4.6.0 (<xref rid="r57" ref-type="bibr">57</xref>). Transcriptional regulation of specific gene signatures was assessed by analysis of single transcription factor binding site enrichment analysis (<ext-link ext-link-type="uri" xlink:href="http://opossum.cisreg.ca/oPOSSUM3/">http://opossum.cisreg.ca/oPOSSUM3/</ext-link>). Pathway and Gene Ontology overrepresentation analysis was performed using InnateDB (<ext-link ext-link-type="uri" xlink:href="http://www.innatedb.com/">http://www.innatedb.com/</ext-link>).</p>
              </sec>
            </sec>
            <sec sec-type="results" id="s12">
              <title>Results</title>
              <sec id="s13">
                <title>TLR2 signaling in response to <italic>S. pneumoniae</italic> is dependent on lipoproteins</title>
                <p>Triton-X extracts of the TIGR4 Δ<italic>lgt S. pneumoniae</italic> strain confirmed that this strain has almost no detectable lipoproteins, similar to the previously described 0100993 Δ<italic>lgt</italic> strain (<xref ref-type="fig" rid="fig01">Fig. 1A</xref>) (<xref rid="r45" ref-type="bibr">45</xref>). A reporter assay was used to assess whether loss of lipoproteins significantly affected TLR2 signaling by <italic>S. pneumoniae</italic> (<xref ref-type="fig" rid="fig01">Fig. 1B</xref>). Live whole TIGR4 WT bacteria stimulated a strong TLR2-dependent signal, whereas live Δ<italic>lgt</italic> bacteria did not cause any significant response even with high multiplicities of infection (MOI). Lysed bacteria gave similar results, demonstrating that impaired growth or failure of release of nonlipoprotein TLR2 ligands such as PG and LTA was not responsible for the lack of TLR2 response to the Δ<italic>lgt</italic> bacteria. We have not been able to complement the Δ<italic>lgt</italic> mutation (<xref rid="r45" ref-type="bibr">45</xref>); hence, to confirm linkage of the loss of TLR2 responses to the mutation, we transferred the mutation to the D39 <italic>S. pneumoniae</italic> strain and obtained similar results to the TIGR4 strain, with almost complete loss of TLR2-dependent signaling to both live and lysed D39Δ<italic>lgt</italic> (<xref ref-type="fig" rid="fig01">Fig. 1C</xref>). Whole-genome sequencing of the Δ<italic>lgt</italic> TIGR4 and D39 <italic>S. pneumoniae</italic> strains was performed to identify unexpected mutations that might confound the results (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Table I</ext-link>). Both the D39 and TIGR4 Δ<italic>lgt</italic> strains contained the expected complete deletion of <italic>lgt</italic> (replaced by the <italic>kan</italic> antibiotic resistance gene), as well as two synonymous single nucleotide polymorphisms (SNPs) in the gene immediately downstream of <italic>lgt</italic> (Spd_1244 and Sp_1413, respectively) that encodes a Hpr(Ser) kinase/phosphatase. In addition, the Δ<italic>lgt</italic> TIGR4 strain contained one SNP in a noncoding intergenic region, and one nonsynonymous SNP changing a histidine for an arginine at position 336 of a 413-aa residue protein encoded by Sp_2175 (<italic>dltB</italic>), predicted to be an alanine exporter involved in lipoteichoic acid synthesis. These data indicate that loss of TLR2 stimulation was linked to deletion of <italic>lgt</italic> and suggest that lipoproteins are major <italic>S. pneumoniae</italic> TLR2 ligands.</p>
                <fig id="fig01" fig-type="figure" position="float">
                  <label>FIGURE 1.</label>
                  <caption>
                    <p>TLR2 activation by <italic>S. pneumoniae</italic> is dependent on surface lipoproteins. (<bold>A</bold>) Coomassie blue staining of Triton-X–extracted membrane proteins from the WT (TIGR4) and TIGR4<italic>Δlgt</italic> strains separated by SDS-PAGE, confirming markedly reduced lipoprotein content for the <italic>Δlgt</italic> strain. A molecular mass marker (15–80 kDa) is also shown. (<bold>B</bold> and <bold>C</bold>) Mean relative absorbance (OD<sub>650</sub>) of supernatants from a TLR2/HEK reporter cell line incubated for 16 h with different MOI of live (empty columns) or lysed (gray columns, using deoxycholate) (B) TIGR4<italic>Δlgt</italic> or TIGR4 and (C) D39<italic>Δlgt</italic> or D39 <italic>S. pneumoniae</italic>. Error bars represent SEMs, and <italic>n</italic> = 3 with data representative of repeated experiments.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f1"/>
                </fig>
              </sec>
              <sec id="s14">
                <title>Mouse macrophage TNF-α response to <italic>S. pneumoniae</italic> is dependent on lipoproteins</title>
                <p>To assess the significance of lipoprotein-dependent TLR2 signaling on the strength of the inflammatory response to <italic>S. pneumoniae</italic>, TNF-α secretion by the RAW mouse macrophage cell line was compared after incubation with WT or Δ<italic>lgt</italic> TIGR4. Significant production of TNF-α was evident after 2-h incubation with WT <italic>S. pneumoniae</italic> (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>), but was significantly attenuated in response to the Δ<italic>lgt</italic> strain at 2, 4, and 24 h (<xref ref-type="fig" rid="fig02">Fig. 2A</xref>, <xref ref-type="fig" rid="fig02">2B</xref>). Loss of lipoproteins affects <italic>S. pneumoniae</italic> growth (<xref rid="r45" ref-type="bibr">45</xref>), and after 4-h incubation with RAW cells there are ∼60% fewer Δ<italic>lgt</italic> bacteria/ml than the WT strain (<xref ref-type="fig" rid="fig02">Fig. 2C</xref>). However, the reduced TNF-α response to the Δ<italic>lgt</italic> strain persisted when RAW cells were stimulated with sonicated bacteria (<xref ref-type="fig" rid="fig02">Fig. 2D</xref>), and after transfer of the <italic>lgt</italic> mutation to the Δ<italic>pabB</italic> strain (<xref ref-type="fig" rid="fig02">Fig. 2C</xref>), an auxotrophic mutant that replicates poorly without addition of exogenous para-aminobenzoic acid (<xref rid="r47" ref-type="bibr">47</xref>). Furthermore, there was a similar scale reduction in the RAW cell TNF-α response to the Δ<italic>lgt</italic> strain when RAW cells were stimulated with Triton-X extracts for 4 h, providing further evidence of a direct effect of lipoproteins on inflammatory responses (<xref ref-type="fig" rid="fig02">Fig. 2E</xref>).</p>
                <fig id="fig02" fig-type="figure" position="float">
                  <label>FIGURE 2.</label>
                  <caption>
                    <p>Macrophage TNF-α responses are dependent on <italic>S. pneumoniae</italic> lipoproteins. (<bold>A</bold> and <bold>B</bold>) Time course of TNF-α concentrations (measured by ELISA) in RAW cell culture supernatants after incubation with TIGR4 or TIGR4<italic>Δlgt S. pneumoniae</italic> (MOI 5). (<bold>C</bold>) TNF-α concentrations in RAW cell culture supernatants after 4-h incubation with Pam<sub>2</sub>CSK<sub>4</sub>, WT, TIGR4<italic>Δlgt</italic>, TIGR4<italic>ΔpabB</italic>, or TIGR4<italic>ΔlgtΔpabB S. pneumoniae</italic>. Bacterial CFU after 4-h incubation are stated above each column. (<bold>D</bold>) TNF-α concentrations in RAW cell culture supernatants after incubation for 4 and 24 h with the TLR agonist Pam<sub>2</sub>CSK<sub>4</sub>, or sonicated TIGR4 or TIGR4<italic>Δlgt S. pneumoniae</italic>. (<bold>E</bold>) TNF-α concentrations in RAW cell culture supernatants after 4-h incubation with TIGR4 or TIGR4<italic>Δlgt S. pneumoniae</italic> or their corresponding 3.3% Triton X-114 lipoprotein. For all panels, <italic>n</italic> = 3–4 and is representative of repeated experiments, data are presented as means, error bars represent SEMs, and <italic>p</italic> values were obtained using unpaired <italic>t</italic> tests.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f2"/>
                </fig>
              </sec>
              <sec id="s15">
                <title>The Δlgt mutation has no effect on PGN structure</title>
                <p>As the PGN synthesis enzyme PGN deacetylase is a hypothetical lipoprotein, PGN structure could potentially be affected by deletion of <italic>lgt</italic> (<xref rid="r58" ref-type="bibr">58</xref>). However, the muropeptide profile of the Δ<italic>lgt</italic> TIGR4 strain did not significantly differ from that of WT TIGR4, and both were similar to the reported muropeptide profile of strain R6 (an unencapsulated derivative of D39) (<xref rid="r53" ref-type="bibr">53</xref>). Importantly, PGN from Δ<italic>lgt</italic> TIGR4 contained peaks corresponding to muropeptide with deacetylated Glc<italic>N</italic>Ac residues, which are generated by PGN deacetylase (<xref rid="r53" ref-type="bibr">53</xref>, <xref rid="r58" ref-type="bibr">58</xref>). To further confirm the presence of deacetylated muropeptides in the Δ<italic>lgt</italic> TIGR4 sample, the main deacetylated monomer (peak 1, <xref ref-type="fig" rid="fig03">Fig. 3</xref>) was analyzed by mass spectrometry (MS). The obtained neutral mass of 783.3880 Da is consistent with the theoretical mass of 783.3862 Da for the deacetylated disaccharide tripeptide (Glc<italic>N</italic>-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys). The MS/MS fragmentation pattern of this signal showed the expected loss of a dehydrated glucosamine residue (160.9152 Da, theoretical 161.0688). Therefore, there are no significant alterations in PGN structure that could account for the effects of the Δ<italic>lgt</italic> mutation on inflammatory responses to <italic>S. pneumoniae</italic>.</p>
                <fig id="fig03" fig-type="figure" position="float">
                  <label>FIGURE 3.</label>
                  <caption>
                    <p>Normal muropeptide profile for PGN from the TIGR4Δ<italic>lgt</italic> strain. HPLC analysis of muropeptides isolated from cell wall preparations of the TIGR4 and TIGR4Δ<italic>lgt</italic> strains. Major muropeptides are indicated by numbers, as follows: 1, Glc<italic>N</italic>-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys; 2, Glc<italic>N</italic>Ac-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys; 3, Glc<italic>N</italic>Ac-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys-L-Ser-L-Ala; 4, Glc<italic>N</italic>Ac-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys-D-Ala-L-Lys-D-iGln-L-Ala-Mur<italic>N</italic>Ac-Glc<italic>N</italic>Ac; 5, Glc<italic>N</italic>Ac-Mur<italic>N</italic>Ac-L-Ala-D-iGln-L-Lys-L-Ser-L-Ala-D-Ala-L-Lys-D-iGln-L-Ala-Mur<italic>N</italic>Ac-Glc<italic>N</italic>Ac. The structure of peak 1 (arrow) was confirmed by mass spectrometry. Glc<italic>N</italic>, glucosamine; Glc<italic>N</italic>Ac, <italic>N</italic>-acetylglucosamine; Mur<italic>N</italic>Ac, <italic>N</italic>-acetylmuramic acid.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f3"/>
                </fig>
              </sec>
              <sec id="s16">
                <title><italic>S. pneumoniae</italic> lipoprotein effects on macrophage TNF-α responses are TLR2 dependent</title>
                <p>To investigate whether the differences in TNF-α responses between the WT and <italic>Δlgt</italic> strains were attributable to specific TLRs, TNF-α responses by BMDMs from WT, <italic>tlr2<sup>−/−</sup></italic>, <italic>tlr4<sup>−/−</sup></italic>, or <italic>Myd88/trif<sup>−/−</sup></italic> mice were also evaluated. There was no significant TNF-α release by BMDMs from <italic>Myd88/trif<sup>−/−</sup></italic> mice incubated with either the WT or <italic>Δlgt</italic> strain, showing the necessity of TLR signaling for the TNF-α response to <italic>S. pneumoniae</italic> (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>). WT TIGR4 induced significantly greater TNF-α secretion by BMDMs from WT mice than the Δ<italic>lgt</italic> strain. TNF-α release by BMDMs from <italic>tlr2<sup>−/−</sup></italic> mice was strongly reduced in comparison with BMDMs from WT mice, although there was still a residual response compared with <italic>Myd88/trif<sup>−/−</sup></italic> BMDMs (<xref ref-type="fig" rid="fig04">Fig. 4A</xref>, <xref ref-type="fig" rid="fig04">4B</xref>). Importantly, for BMDMs from <italic>tlr2<sup>−/−</sup></italic> mice, there was no increased TNF-α response to WT TIGR4 compared with Δ<italic>lgt</italic> bacteria, indicating that the increase seen with BMDMs from WT mice was TLR2 dependent. In contrast, although TNF-α production by BMDMs from <italic>tlr4<sup>−/−</sup></italic> mice was reduced in response to both strains compared with BMDMs from WT mice, WT TIGR4 still induced significantly higher levels of TNF-α secretion than the Δ<italic>lgt</italic> strain (<xref ref-type="fig" rid="fig04">Fig. 4C</xref>). These results demonstrate that the TLR2 but not the TLR4 response was dependent on bacterial lipoproteins.</p>
                <fig id="fig04" fig-type="figure" position="float">
                  <label>FIGURE 4.</label>
                  <caption>
                    <p><italic>S. pneumoniae</italic> lipoproteins induce proinflammatory cytokines via TLR2 pathway activation. Mean TNF-α concentrations in cell culture supernatants from BMDMs obtained from C57BL/6 mice incubated for 4 h with the TLR agonists (LPS and/or Pam<sub>2</sub>CSK<sub>4</sub>), or TIGR4 or TIGR4<italic>Δlgt S. pneumoniae</italic>. (<bold>A</bold>) Results for BMDMs obtained from WT or <italic>Myd88/trif<sup>−</sup></italic><sup>/−</sup> mice. (<bold>B</bold>) Results for BMDMs obtained from WT or <italic>TLR2<sup>−</sup></italic><sup>/−</sup> mice. (<bold>C</bold>) Results for BMDMs obtained from WT or <italic>TLR4<sup>−</sup></italic><sup>/−</sup> mice. For all panels, <italic>n</italic> = 3–4 and is representative of repeated experiments, error bars represent SEMs, and <italic>p</italic> values were obtained using unpaired <italic>t</italic> tests.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f4"/>
                </fig>
              </sec>
              <sec id="s17">
                <title>Loss of lipoproteins attenuates NF-κB activation in response to <italic>S. pneumoniae</italic></title>
                <p>We then assessed whether loss of TLR2 signaling in response to the Δ<italic>lgt</italic> strain affected activation of the key proinflammatory transcriptional regulator NF-κB (<xref rid="r59" ref-type="bibr">59</xref>, <xref rid="r60" ref-type="bibr">60</xref>) in macrophages. Quantifying NF-κB Rel A in nuclear extracts showed there was a significant increase in BMDM NF-κB activation by WT TIGR4 that was largely abrogated in macrophages from <italic>Myd88/trif<sup>−/−</sup></italic> mice or in WT BMDMs infected with the Δ<italic>lgt</italic> strain (<xref ref-type="fig" rid="fig05">Fig. 5A</xref>). Similarly, NF-κB activation was significantly attenuated in response to the Δ<italic>lgt</italic> strain compared with WT TIGR4 when assessed using a confocal assay to quantify nuclear translocation of NF-κB Rel A in human MDMs (<xref ref-type="fig" rid="fig05">Fig. 5B</xref>, <xref ref-type="fig" rid="fig05">5C</xref>). These data suggest both mouse and human macrophage NF-κB activation in response to <italic>S. pneumoniae</italic> is dependent on TLR recognition of lipoproteins.</p>
                <fig id="fig05" fig-type="figure" position="float">
                  <label>FIGURE 5.</label>
                  <caption>
                    <p>Pneumococcal lipoproteins are important determinants of TLR-induced NF-κB activation. (<bold>A</bold>) Quantification of nuclear NF-κB p65 using MSD (arbitrary units) for BMDMs from C57BL/6 WT and <italic>Myd88/trif<sup>−</sup></italic><sup>/−</sup> mice incubated for 1 h with <italic>Δlgt</italic> and TIGR4 <italic>S. pneumoniae</italic> (MOI of 5). Each symbol represents results for one well, the bar represents median values, and the <italic>p</italic> value for comparison of TIGR4 and <italic>Δlgt</italic> strains incubated with WT BMDMs was obtained using a Mann–Whitney <italic>U</italic> test. (<bold>B</bold>) Confocal immunofluorescence images of NF-κB RelA in human MDM from five different donors stimulated for 2 h with WT (TIGR4) or lipoprotein-deficient (<italic>Δlgt</italic>) <italic>S. pneumoniae</italic> (MOI 5 or 50) showing diminished nuclear translocation of RelA (pink nuclei) for cells incubated with the <italic>Δlgt</italic> strain. (<bold>C</bold>) Quantitative image analysis of the median (IQR) ratio of nuclear to cytoplasmic RelA staining (*<italic>p</italic> = 0.0079, Mann–Whitney <italic>U</italic> test).</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f5"/>
                </fig>
              </sec>
              <sec id="s18">
                <title>Comparison of the macrophage transcriptome to the TIGR4 and Δlgt strains</title>
                <p>To provide detailed data on the effect of lipoproteins on global inflammatory responses to <italic>S. pneumoniae</italic>, human MDM genome-wide transcriptional responses were compared after incubation for 4 h with live WT or Δ<italic>lgt</italic> TIGR4 bacteria, or the specific TLR2 agonist Pam<sub>2</sub>CSK<sub>4</sub>. All three stimuli caused major changes in gene expression; Pam<sub>2</sub>CSK<sub>4</sub> and WT TIGR4 stimulated the increased expression of 854 and 936 genes, respectively, with the Δ<italic>lgt</italic> strain causing upregulated expression of slightly fewer genes (591 in total) (<xref ref-type="fig" rid="fig06">Fig. 6A</xref>, <xref ref-type="fig" rid="fig06">6B</xref>). Although there was a large overlap in the genes upregulated by Pam<sub>2</sub>CSK<sub>4</sub>, WT TIGR4, and the Δ<italic>lgt</italic> strain, there was greater overlap with Pam<sub>2</sub>CSK<sub>4</sub> for responses to WT TIGR4 than for Δ<italic>lgt</italic>, in keeping with the hypothesis that <italic>S. pneumoniae</italic> lipoproteins are important for TLR2-associated transcriptional responses.</p>
                <fig id="fig06" fig-type="figure" position="float">
                  <label>FIGURE 6.</label>
                  <caption>
                    <p>Attenuated TLR2-associated macrophage transcriptional responses in response to lipoprotein-deficient <italic>S. pneumoniae</italic>. Comparison of MDM genome-wide transcriptional responses from at least three donors after 4-h stimulation with Pam<sub>2</sub>CSK<sub>4</sub>, WT (TIGR4), or <italic>Δlgt S. pneumoniae</italic>. (<bold>A</bold>) Total number of genes upregulated at least &gt;2-fold. (<bold>B</bold>) Venn diagram of the overlap between the genes upregulated &gt;2-fold by each stimulus. (<bold>C</bold>) PC analysis showing quantitative differences in expression levels of cocorrelated gene signatures in the global gene expression profile. The graph plots PC1 and PC2, responsible for the greatest differences, for each condition (data points represent mean ± SEM of ≥3 separate experiments). (<bold>D</bold> and <bold>E</bold>) The gene expression heat map shows the transcriptional response (compared with unstimulated MDM) for the top 50 genes that contribute to PC1 (D) and PC2 (E).</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f6"/>
                </fig>
                <p>PC analysis was used to explore differences in cocorrelated gene expression data. In PC1, which reflects the greatest gene expression differences between stimulated and unstimulated macrophages, the effects of WT TIGR4 were equivalent to those of Pam<sub>2</sub>CSK<sub>4</sub>. However, Δ<italic>lgt</italic>-induced changes in gene expression were reduced for this component (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>, <xref ref-type="fig" rid="fig06">6D</xref>). In contrast, the Δ<italic>lgt</italic> and WT TIGR4 strains induced comparable changes to gene expression in PC2, distinct from those induced by Pam<sub>2</sub>CSK<sub>4</sub> and therefore by inference independent of TLR2 (<xref ref-type="fig" rid="fig06">Fig. 6C</xref>, <xref ref-type="fig" rid="fig06">6E</xref>). This analysis is consistent with the Venn diagram of qualitative transcriptional responses to these stimuli, which showed that MDMs stimulated with the Δ<italic>lgt</italic> and TIGR4 strains shared increased expression of 320 genes that were not upregulated following specific TLR2 stimulation by Pam<sub>2</sub>CSK<sub>4</sub> (<xref ref-type="fig" rid="fig06">Fig. 6B</xref>). Bioinformatic analysis of the top 50 genes that reflected <italic>S. pneumoniae</italic> TLR2-dependent responses in PC1 and TLR-2 independent responses in PC2 is presented in <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 1</ext-link>. Transcription factor binding site enrichment analyses revealed the dominance of NF-κB–regulated genes in PC1, associated with enrichment for proinflammatory cytokines reflected by pathway and gene ontology analysis (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 1</ext-link>). In contrast, TLR2-independent responses to <italic>S. pneumoniae</italic> reflected in PC2 showed markedly less enrichment for NF-κB–regulated genes, with modest enrichment for genes associated with nucleosome and transcriptional regulation instead. Taken together, these data suggest that the canonical inflammatory responses to TIGR4 are mediated by TLR2 and are attenuated in response to the Δ<italic>lgt</italic> strain. However, non-TLR2 transcriptional responses were largely comparable in MDMs stimulated with either the Δ<italic>lgt</italic> or TIGR4 strains.</p>
                <p>The genes showing the greatest differences in expression between MDMs stimulated with Δ<italic>lgt</italic> and TIGR4 strains included the cytokines IL-23, IL-6, and IL-1β, and the chemokines CXCL1, CXCL2, and CXCL3 (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 2A</ext-link>), and transcriptional factor binding site analysis showed enrichment for regulation by NF-κB (<xref ref-type="table" rid="tI">Table I</xref>) in keeping with the data shown in <xref ref-type="fig" rid="fig05">Fig. 5</xref> and <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 1</ext-link>. Selected differences in expression of prototypic inflammatory genes identified by microarray were validated by qPCR. <italic>IL-23</italic>, <italic>IL-6</italic>, and <italic>PTGS2</italic> expression were all significantly lower in macrophages stimulated with the Δ<italic>lgt</italic> strain compared with WT TIGR4, confirming the transcriptome results (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 2A–E</ext-link>). Although the microarray and qPCR analysis showed no difference in TNF-α expression induced by the two strains (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 2A, 2F</ext-link>), both TNF-α and IL-6 production by macrophages were attenuated in response to the Δ<italic>lgt</italic> strain (<ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 2G</ext-link>). Similarly, reduced levels of IL-1β, IL-6, and TNF-α were present in supernatants from human PBMCs stimulated with the Δ<italic>lgt</italic> strain compared with TIGR4 (<xref ref-type="table" rid="tII">Table II</xref>).</p>
                <table-wrap id="tI" position="float">
                  <label>Table I.</label>
                  <caption>
                    <title>Transcription factor enrichment of gene expression differences between MDMs stimulated with TIGR4 and ∆lgt</title>
                  </caption>
                  <table frame="above" rules="groups">
                    <col width="29.71%" span="1"/>
                    <col width="31.32%" span="1"/>
                    <col width="24.04%" span="1"/>
                    <col width="14.93%" span="1"/>
                    <thead>
                      <tr>
                        <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">Transcription Factor</th>
                        <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Background TFBS Rate</th>
                        <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Target TFBS Rate</th>
                        <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Z-Score<xref ref-type="table-fn" rid="tIn1"><italic><sup>a</sup></italic></xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">RELA</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0035</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0103</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">26.16</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">NF-κB</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0050</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0118</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">22.11</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">REL</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0081</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0167</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">21.66</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">HLF</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0049</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0109</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">19.48</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">NFKB1</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0020</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0053</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">17.10</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">NFIL3</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0033</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0066</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">13.19</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">STAT1</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0016</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0038</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">12.10</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Foxq1</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0060</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0100</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">11.71</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">Ar</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0006</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0017</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">10.32</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="tIn1">
                      <label>
                        <sup>
                          <italic>a</italic>
                        </sup>
                      </label>
                      <p>Z-scores of &gt;10 are considered to indicate highly significant overrepresentation of TFBS within the analyzed gene list.</p>
                    </fn>
                    <fn>
                      <p>TFBS, transcription factor binding site.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <table-wrap id="tII" position="float">
                  <label>Table II.</label>
                  <caption>
                    <title>Mean (SEM) cytokine responses in pg/ml 4 h after incubation of PBMCs from five donors with the TIGR4 wild-type and Δlgt <italic>S. pneumoniae</italic> strains</title>
                  </caption>
                  <table frame="above" rules="groups">
                    <col width="13.93%" span="1"/>
                    <col width="18.12%" span="1"/>
                    <col width="17.13%" span="1"/>
                    <col width="19.22%" span="1"/>
                    <col width="17.62%" span="1"/>
                    <col width="13.98%" span="1"/>
                    <thead>
                      <tr>
                        <th rowspan="2" valign="top" align="left" scope="col" colspan="1">Cytokine</th>
                        <th colspan="4" valign="top" align="center" scope="colgroup" rowspan="1">Conditions<hr/></th>
                        <th rowspan="2" valign="top" align="center" scope="col" colspan="1"><italic>p</italic> for TIGR4 vs. Δ<italic>lgt</italic></th>
                      </tr>
                      <tr>
                        <th valign="top" colspan="1" align="center" scope="colgroup" rowspan="1">Unstimulated</th>
                        <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Pam<sub>2</sub>CSK<sub>4</sub></th>
                        <th valign="top" align="center" scope="col" rowspan="1" colspan="1">TIGR4</th>
                        <th valign="top" align="center" scope="col" rowspan="1" colspan="1">Δ<italic>lgt</italic></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IFN-γ</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">34 (9.6)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">94 (16)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">56 (16)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">38 (9.9)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">NS</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IL-10</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">4.7 (1.2)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">58 (25)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">6.8 (1.7)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">16 (10)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">NS</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IL-12</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">3.1 (1.3)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">9.8 (0.5)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">10 (1.1)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">6.5 (1.7)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">NS</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IL-1β</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">30 (9.9)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">1,410 (433)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">7,040 (634)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">3,260 (501)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.0016</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IL-6</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">127 (25)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">3,340 (797)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">245 (57)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">98 (18)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.040</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">IL-8</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">5,190 (1,180)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">5,210 (715)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">10,780 (1,220)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">8,650 (1,220)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">NS</td>
                      </tr>
                      <tr>
                        <td valign="top" align="left" scope="row" rowspan="1" colspan="1">TNF-α</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">690 (202)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">8,030 (2,160)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">4,710 (965)</td>
                        <td valign="top" align="char" char="(" rowspan="1" colspan="1">1,650 (392)</td>
                        <td valign="top" align="center" rowspan="1" colspan="1">0.019</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn>
                      <p>The <italic>p</italic> values are for comparisons of results obtained with the TIGR4 or <italic>Δlgt</italic> strains (unpaired <italic>t</italic> tests).</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="s19">
                <title>Role of lipoproteins for inflammatory responses to <italic>S. pneumoniae</italic> during infection</title>
                <p>A mouse model was used to investigate the role of lipoproteins for inflammatory responses to <italic>S. pneumoniae</italic> during lung infection. As the <italic>Δlgt</italic> strain cannot replicate efficiently under in vivo conditions and is highly attenuated in virulence (<xref rid="r45" ref-type="bibr">45</xref>), only a short-term infection model could be used. To reduce differences in bacterial CFU confounding the results, the experiments were performed in the Δ<italic>pabB</italic> background, which is unable to replicate during infection (<xref rid="r47" ref-type="bibr">47</xref>). Four hours after intranasal inoculation with 10<sup>7</sup> CFU, BALF TNF-α and IL-1β levels were raised in response to the Δ<italic>pabB</italic> strain compared with the Δ<italic>pabB/</italic>Δ<italic>lgt</italic> strain (<xref ref-type="fig" rid="fig07">Fig. 7A</xref>, <xref ref-type="fig" rid="fig07">7B</xref>) despite similar BALF CFU (5.14 and 5.16 log<sub>10</sub> CFU/ml, respectively). BALF IL-6 levels were similar for both strains, although in vitro IL-6 release by BMDMs was dependent on TLR2 and reduced in response to the Δ<italic>lgt</italic> strain (<xref ref-type="fig" rid="fig07">Fig. 7C</xref>, <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">Supplemental Fig. 3</ext-link>). Neither strain caused a significant increase in BALF cellularity at this early time point (<xref ref-type="fig" rid="fig07">Fig. 7D</xref>).</p>
                <fig id="fig07" fig-type="figure" position="float">
                  <label>FIGURE 7.</label>
                  <caption>
                    <p>Effects of lipoproteins during early lung infection. CD1 mice (<italic>n</italic> = 5–6) were inoculated intranasally with 1 × 10<sup>7</sup> CFU TIGR4<italic>ΔpabB</italic> or <italic>Δlgt</italic>/<italic>pabB</italic> and BALF obtained at 4 h. BALF TNF-α (<bold>A</bold>), IL-1β (<bold>B</bold>), and IL-6 (<bold>C</bold>) (PBS control data obtained during a separate infection experiment) levels measured by ELISA. (<bold>D</bold>) BALF total cell count. Each symbol represents results from a single mouse, and the bars medians. The <italic>p</italic> values were obtained using Mann–Whitney <italic>U</italic> tests.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f7"/>
                </fig>
              </sec>
              <sec id="s20">
                <title>IRAK-4–dependent release of protective proinflammatory cytokines from human PBMCs is largely dependent on lipoproteins</title>
                <p>To further assess the clinical relevance of TLR-dependent inflammatory responses to lipoproteins, the WT TIGR4 and Δ<italic>lgt</italic> strains were incubated with PBMCs obtained from two humans with IRAK-4 deficiency, and cytokine transcriptional and protein responses were measured. High levels of TNF-α and IL-1β were found in supernatants from healthy control PBMCs incubated with WT TIGR4. In contrast, incubation of healthy control PBMCs with the Δ<italic>lgt</italic> strain or IRAK-4<sup>−/−</sup> PBMCs with either WT or Δ<italic>lgt</italic> TIGR4 resulted in similar reduced levels of TNF-α and IL-1β (<xref ref-type="fig" rid="fig08">Fig. 8A</xref>, <xref ref-type="fig" rid="fig08">8B</xref>). In these experiments, no significant PBMC IL-6 response was detected (<xref ref-type="fig" rid="fig08">Fig. 8C</xref>). qPCR demonstrated increased expression of <italic>TNFα</italic>, <italic>IL1-β</italic>, and <italic>IL-6</italic> by control PBMCs in response to WT TIGR4, a response that was significantly attenuated in PBMCs from IRAK-4–deficient individuals (<xref ref-type="fig" rid="fig08">Fig. 8D–F</xref>). In contrast, there was no induction of <italic>IL-1β</italic> and <italic>IL-6</italic> gene expression by the Δ<italic>lgt</italic> strain in either control or IRAK-4–deficient PBMCs (<xref ref-type="fig" rid="fig08">Fig. 8E</xref>, <xref ref-type="fig" rid="fig08">8F</xref>) and reduced <italic>TNF-α</italic> expression by control PBMCs (<xref ref-type="fig" rid="fig08">Fig. 8D</xref>). Overall, these data show that important components of the IRAK-4–dependent inflammatory response to <italic>S. pneumoniae</italic> are considerably reduced in response to the Δ<italic>lgt</italic> strain, indicating that lipoproteins are likely to be major stimuli for IRAK-4–dependent immune responses.</p>
                <fig id="fig08" fig-type="figure" position="float">
                  <label>FIGURE 8.</label>
                  <caption>
                    <p>IRAK4-dependent production of proinflammatory cytokines is largely lipoprotein dependent. PBMCs from three healthy volunteers and two IRAK4-deficient patients were stimulated for 4 h with TIGR4 or <italic>Δlgt S. pneumoniae</italic> (MOI 10). (<bold>A</bold>–<bold>C</bold>) Mean TNF-α (A), IL-1β (B), and IL-6 (C) concentrations measured by ELISA in cell culture supernatants. (<bold>D</bold>–<bold>F</bold>) qPCR of <italic>TNF-α</italic> (D), <italic>IL-1β</italic> (E), and <italic>IL-6</italic> (F) gene expression (relative to <italic>GAPDH</italic>). Each symbol represents results from a single donor.</p>
                  </caption>
                  <graphic xlink:href="JI_1401413_f8"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s21">
              <title>Discussion</title>
              <p><italic>S. pneumoniae</italic> infections cause a strong NF-κB–mediated proinflammatory response that is essential for host immunity but also causes some of the important features of severe infection (<xref rid="r2" ref-type="bibr">2</xref>–<xref rid="r4" ref-type="bibr">4</xref>, <xref rid="r60" ref-type="bibr">60</xref>). This inflammatory response has previously been shown to be partially dependent on TLR2 (<xref rid="r18" ref-type="bibr">18</xref>, <xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r23" ref-type="bibr">23</xref>, <xref rid="r24" ref-type="bibr">24</xref>, <xref rid="r61" ref-type="bibr">61</xref>). In addition, TLR2 responses are required for Th17 and some humoral adaptive immune responses (<xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r28" ref-type="bibr">28</xref>, <xref rid="r29" ref-type="bibr">29</xref>). Identifying the <italic>S. pneumoniae</italic> TLR2 ligands is important for our understanding of disease pathogenesis and for the design of therapeutic manipulations aimed at modifying inflammatory responses or improving humoral and cellular immunity to <italic>S. pneumoniae</italic>. Although the cell wall components PGN and LTA are proinflammatory <italic>S. pneumoniae</italic> ligands thought to be recognized by TLR2 (<xref rid="r33" ref-type="bibr">33</xref>–<xref rid="r35" ref-type="bibr">35</xref>), recent evidence suggests they may stimulate inflammatory responses by TLR2-independent mechanisms (<xref rid="r36" ref-type="bibr">36</xref>–<xref rid="r38" ref-type="bibr">38</xref>). In contrast to the extensive data on PGN and LTA, the potential role of lipoproteins as proinflammatory stimuli during <italic>S. pneumoniae</italic> infections has not been characterized. We have now explored the role of lipoproteins as <italic>S. pneumoniae</italic> proinflammatory ligands using the Δ<italic>lgt</italic> strain (<xref rid="r45" ref-type="bibr">45</xref>), which allows the effects of lipoproteins to be assessed in the context of the whole bacterium rather than relying on purified products.</p>
              <p>Our results demonstrated that <italic>S. pneumoniae</italic> lipoproteins are major contributors to the macrophage TLR- and NF-κB–mediated inflammatory response. In theory, the effects of the Δ<italic>lgt</italic> mutation on the physiology of <italic>S. pneumoniae</italic> (<xref rid="r45" ref-type="bibr">45</xref>) could have confounded these results, but control experiments demonstrated persistent decreases in macrophage inflammatory responses to the Δ<italic>lgt</italic> strain when live or nonreplicating (to control for bacterial CFU) bacteria were used. The data obtained by the nonreplicating <italic>ΔpabB</italic> strains could also have been confounded by the dual mutation in the <italic>Δlgt/pabB</italic> strain compared with the <italic>ΔpabB</italic> strain; however, additional control experiments also showed reduced inflammatory responses to lipoprotein extracts or sonicated bacteria (to release cell wall fragments) from the <italic>Δlgt</italic> strain compared with WT. Differences in TNF-α responses to TIGR4 and Δ<italic>lgt</italic> strains were lost for macrophages from TLR2 mice and preserved for macrophages from TLR4 mice. Of the surface structures that affect interactions with the host, <italic>S. pneumoniae</italic> LTA has recently been shown not to affect TLR2 responses (<xref rid="r38" ref-type="bibr">38</xref>), and we have shown no effect of the Δ<italic>lgt</italic> mutation on PGN structure and (in a previous publication) on neutrophil killing of <italic>S. pneumoniae</italic>, a phenotype suggesting the capsule is unaffected (<xref rid="r45" ref-type="bibr">45</xref>). Furthermore, two papers have shown the capsule has limited effects on inflammation (<xref rid="r62" ref-type="bibr">62</xref>, <xref rid="r63" ref-type="bibr">63</xref>), and, although a third suggests capsule material can induce inflammatory responses (<xref rid="r64" ref-type="bibr">64</xref>), these were measured at a much later time point than our data and may be confounded by contamination of capsule polysaccharide with cell wall or lipoprotein. Hence, it is unlikely that the differences in inflammatory responses seen between WT and Δ<italic>lgt</italic> strains were confounded by effects of the mutation on bacterial physiology, PGN structure, or the capsule. Complementing the <italic>Δlgt</italic> mutation would have been beneficial, but for poorly understood reasons <italic>S. pneumoniae</italic> mutant strains can be difficult to complement, and our attempts to complement the <italic>Δlgt</italic> mutant failed (<xref rid="r45" ref-type="bibr">45</xref>). Instead, we used whole-genome sequencing and transfer of the mutation to another strain to link the phenotypes seen to deletion of <italic>lgt</italic>. These results indicate that lipoproteins are major TLR2 ligands for <italic>S. pneumoniae</italic>, similar to results obtained with other Gram-positive pathogens (<xref rid="r39" ref-type="bibr">39</xref>, <xref rid="r40" ref-type="bibr">40</xref>, <xref rid="r51" ref-type="bibr">51</xref>, <xref rid="r65" ref-type="bibr">65</xref>).</p>
              <p>We used transcriptional arrays, qPCR, and supernatant cytokine levels to confirm decreased expression of a variety of proinflammatory cytokines and chemokines for macrophages infected with the Δ<italic>lgt</italic> strain. There were some discrepancies between transcriptional and protein level data with, for example, consistently reduced levels of TNF-α protein in response to infection of MDMs, BMDMs, and PBMCs despite little change in gene transcription at the 4-h time point, which may reflect release of preformed TNF-α. In addition, significant levels of IL-1β, IL-6, and TNF-α were still produced by leukocytes in response to the <italic>Δlgt</italic> strain, potentially reflecting inflammatory responses induced by NOD2-mediated recognition of PGN and pneumolysin activation of the inflammasome and/or TLR4 (<xref rid="r16" ref-type="bibr">16</xref>, <xref rid="r27" ref-type="bibr">27</xref>, <xref rid="r36" ref-type="bibr">36</xref>, <xref rid="r37" ref-type="bibr">37</xref>, <xref rid="r66" ref-type="bibr">66</xref>, <xref rid="r67" ref-type="bibr">67</xref>). These mechanisms combined with residual TLR2 activation may explain why the macrophage proinflammatory gene transcriptional responses to the Δ<italic>lgt</italic> strain were reduced rather than absent compared with WT TIGR4. These results are also consistent with published data showing more marked effects of MyD88 deficiency than loss of individual TLRs on inflammatory response to <italic>S. pneumoniae</italic> in mice and humans (<xref rid="r8" ref-type="bibr">8</xref>, <xref rid="r11" ref-type="bibr">11</xref>, <xref rid="r17" ref-type="bibr">17</xref>, <xref rid="r19" ref-type="bibr">19</xref>, <xref rid="r21" ref-type="bibr">21</xref>). As TLR2 activation increases TLR4-, pneumolysin-, and NOD2-dependent inflammatory responses to <italic>S. pneumoniae</italic> (<xref rid="r21" ref-type="bibr">21</xref>, <xref rid="r26" ref-type="bibr">26</xref>, <xref rid="r27" ref-type="bibr">27</xref>), <italic>S. pneumoniae</italic> lipoproteins may also increase inflammatory responses indirectly through these other mechanisms of innate immune recognition.</p>
              <p>The global assessment of macrophage responses by transcriptional profiling significantly improves our understanding of key interactions of the host with <italic>S. pneumoniae</italic>. <italic>S. pneumoniae</italic> caused major changes in macrophage gene expression, with upregulation of &gt;900 genes in response to the WT TIGR4 strain. Many genes showing large differences in expression between control macrophages and those infected with TIGR4 <italic>S. pneumoniae</italic> were equally expressed in response to infection with the <italic>Δlgt</italic> strain. However, the small proportion of genes with differences in expression between the WT and <italic>Δlgt</italic> strain was concentrated in the transcriptional responses with the greatest upregulation in response to <italic>S. pneumoniae</italic> (PC1), which also responded to Pam<sub>2</sub>CSK<sub>4</sub> stimulation. These data show that macrophage transcriptional responses to <italic>S. pneumoniae</italic> are dominated by TLR2-dependent genes that often require the presence of lipoproteins for maximal stimulation, with a larger number of generally weaker changes in expression of genes whose responses are TLR2 independent. The list of TLR2-dependent genes has a striking preponderance for genes encoding important proinflammatory proteins that bioinformatic analysis suggests are largely activated by the NF-κB pathway, in keeping with the data showing reduced NF-κB activation in response to the <italic>Δlgt</italic> strain. Our data contrast with those showing that pneumolysin induced macrophage expression of very few genes encoding chemokines or cytokines (<xref rid="r68" ref-type="bibr">68</xref>).</p>
              <p>The potential clinical relevance of <italic>S. pneumoniae</italic> lipoprotein-dependent inflammation was assessed in a mouse model of pneumonia, and using PBMCs from individuals with IRAK-4 deficiency. We were able to demonstrate that the rapid TNF-α and IL-1β responses during early lung infection with <italic>S. pneumoniae</italic> were reduced in response to the Δ<italic>lgt</italic> strain. Despite the effect of lipoproteins on the IL-6 response in vitro, BALF IL-6 responses were similar for mice infected with the TIGR4 or Δ<italic>lgt</italic> strain. Potentially, differences in IL-6 levels could develop later in infection, but as the Δl<italic>gt</italic> strain cannot maintain long-term infection in mouse models (<xref rid="r45" ref-type="bibr">45</xref>), it was not feasible to investigate this. The striking susceptibility of children with IRAK-4 deficiency to invasive <italic>S. pneumoniae</italic> infections demonstrates the vital importance of inflammatory responses for immunity to this pathogen during childhood (<xref rid="r5" ref-type="bibr">5</xref>, <xref rid="r6" ref-type="bibr">6</xref>, <xref rid="r9" ref-type="bibr">9</xref>, <xref rid="r10" ref-type="bibr">10</xref>), but the <italic>S. pneumoniae</italic> ligands responsible have not been identified. In mouse models of infection, IL-1β, IL-6, and TNF-α are important protective cytokines during <italic>S. pneumoniae</italic> infection (<xref rid="r13" ref-type="bibr">13</xref>–<xref rid="r15" ref-type="bibr">15</xref>), and we have now demonstrated that expression of these cytokines by healthy controls was largely dependent on lipoproteins. Importantly, WT PBMCs IL-1β, IL-6, and TNF-α responses to the Δ<italic>lgt</italic> strain were attenuated at the transcriptional and (for IL-1β and TNF-α) protein level, similar to the results for WT TIGR4 incubated with PBMCs obtained from IRAK4-deficient subjects. Due to the limited number of donors available, only two IRAK4-deficient subjects were available for testing. Despite this, the results were highly consistent between the two donors and suggest that lipoproteins are important ligands driving IRAK-4–dependent inflammatory responses and therefore protective immunity in children.</p>
              <p>Overall, our data demonstrate that lipoproteins are major <italic>S. pneumoniae</italic> TLR2 ligands that are required for the maximum transcriptional response for many of the dominant macrophage gene responses to <italic>S. pneumoniae</italic>, including induction of IRAK-4–dependent protective cytokines. Specific targeting of bacterial lipoprotein/TLR2 inflammatory responses could be a novel therapeutic approach for enhancing cellular and humoral immune responses to vaccines or, when combined with effective antibiotic therapy, for improving the outcome of severe <italic>S. pneumoniae</italic> infections.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supplementary Material</title>
              <supplementary-material id="PMC_1" content-type="local-data">
                <caption>
                  <title>Data Supplement</title>
                </caption>
                <media mimetype="text" mime-subtype="html" xlink:href="supp_193_7_3736__index.html"/>
                <media xlink:role="associated-file" mimetype="application" mime-subtype="pdf" xlink:href="1401413_JI_1401413_Supplemental_Material_1.pdf"/>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank Joe Gray (Pinnacle Proteomics Facility, Institute for Cell and Molecular Biosciences, Newcastle University) for mass spectrometry analysis.</p>
            </ack>
            <fn-group>
              <fn id="grant" fn-type="supported-by">
                <p>This work, which was undertaken at University College London Hospitals Trust/University College London, was supported by Department of Health’s National Institute for Health Research Biomedical Research Centre funding scheme; <funding-source id="gs01">Medical Research Council</funding-source> Grants <award-id id="gn01">G0700569</award-id> (to G.T.), <award-id id="gn02">G0700829</award-id> (to J.C.), <award-id id="gn03">G0600410</award-id> (to E.C.), <award-id id="gn04">MR/K00168X/1</award-id> (to J.P.), and <award-id id="gn05">G0801211</award-id> (to T.P.); and <funding-source id="gs02">Wellcome Trust</funding-source> Grants <award-id id="gn06">WT076442</award-id> (to S.C.) and <award-id id="gn07">WT077161</award-id> (to M.N.). S.C. and M.N. were supported by University College London Hospitals charities. S.S., S.C., and M.N. were supported by a grant from the Rosetrees Trust. W.V. was supported by the Biotechnology and Biological Sciences Research Council (BB/G015902/1).</p>
              </fn>
              <fn id="supp" fn-type="supplementary-material">
                <p>The online version of this article contains <ext-link ext-link-type="uri" xlink:href="http://www.jimmunol.org/lookup/suppl/doi:10.4049/jimmunol.1401413/-/DCSupplemental">supplemental material</ext-link>.</p>
              </fn>
            </fn-group>
            <fn-group content-type="abbreviations">
              <fn id="abbr" fn-type="abbr">
                <p>Abbreviations used in this article:<def-list><def-item><term id="G1">BALF</term><def><p>bronchoalveolar lavage fluid</p></def></def-item><def-item><term id="G2">BMDM</term><def><p>bone marrow–derived macrophage</p></def></def-item><def-item><term id="G3">IRAK</term><def><p>IL-1R–associated kinase</p></def></def-item><def-item><term id="G4">LTA</term><def><p>lipoteichoic acid</p></def></def-item><def-item><term id="G5">MDM</term><def><p>monocyte-derived macrophage</p></def></def-item><def-item><term id="G6">MOI</term><def><p>multiplicity of infection</p></def></def-item><def-item><term id="G7">MS</term><def><p>mass spectrometry</p></def></def-item><def-item><term id="G8">PC</term><def><p>principal component</p></def></def-item><def-item><term id="G9">PGN</term><def><p>peptidoglycan</p></def></def-item><def-item><term id="G10">qPCR</term><def><p>quantitative PCR</p></def></def-item><def-item><term id="G11">SNP</term><def><p>single nucleotide polymorphism</p></def></def-item><def-item><term id="G12">WT</term><def><p>wild-type.</p></def></def-item></def-list></p>
              </fn>
            </fn-group>
            <sec id="s22" sec-type="financial-disclosure">
              <title>Disclosures</title>
              <p>The authors have no financial conflicts of interest.</p>
            </sec>
            <ref-list>
              <title>References</title>
              <ref id="r1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Brien</surname><given-names>K. L.</given-names></name><name><surname>Wolfson</surname><given-names>L. J.</given-names></name><name><surname>Watt</surname><given-names>J. P.</given-names></name><name><surname>Henkle</surname><given-names>E.</given-names></name><name><surname>Deloria-Knoll</surname><given-names>M.</given-names></name><name><surname>McCall</surname><given-names>N.</given-names></name><name><surname>Lee</surname><given-names>E.</given-names></name><name><surname>Mulholland</surname><given-names>K.</given-names></name><name><surname>Levine</surname><given-names>O. S.</given-names></name><name><surname>Cherian</surname><given-names>T.</given-names></name><collab>Hib and Pneumococcal Global Burden of Disease Study Team</collab></person-group>. <year>2009</year>. <article-title>Burden of disease caused by <italic>Streptococcus pneumoniae</italic> in children younger than 5 years: global estimates.</article-title><source>Lancet</source><volume>374</volume>: <fpage>893</fpage>–<lpage>902</lpage><pub-id pub-id-type="pmid">19748398</pub-id></mixed-citation>
              </ref>
              <ref id="r2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calbo</surname><given-names>E.</given-names></name><name><surname>Garau</surname><given-names>J.</given-names></name></person-group>. <year>2010</year>. <article-title>Of mice and men: innate immunity in pneumococcal pneumonia.</article-title><source>Int. J. Antimicrob. Agents</source><volume>35</volume>: <fpage>107</fpage>–<lpage>113</lpage><pub-id pub-id-type="pmid">20005681</pub-id></mixed-citation>
              </ref>
              <ref id="r3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizgerd</surname><given-names>J. P.</given-names></name></person-group><year>2008</year>. <article-title>Acute lower respiratory tract infection.</article-title><source>N. Engl. J. Med.</source><volume>358</volume>: <fpage>716</fpage>–<lpage>727</lpage><pub-id pub-id-type="pmid">18272895</pub-id></mixed-citation>
              </ref>
              <ref id="r4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koedel</surname><given-names>U.</given-names></name></person-group><year>2009</year>. <article-title>Toll-like receptors in bacterial meningitis.</article-title><source>Curr. Top. Microbiol. Immunol.</source><volume>336</volume>: <fpage>15</fpage>–<lpage>40</lpage><pub-id pub-id-type="pmid">19688326</pub-id></mixed-citation>
              </ref>
              <ref id="r5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>Casanova</surname><given-names>J. L.</given-names></name><name><surname>Puel</surname><given-names>A.</given-names></name></person-group>. <year>2011</year>. <article-title>Infectious diseases in patients with IRAK-4, MyD88, NEMO, or IκBα deficiency.</article-title><source>Clin. Microbiol. Rev.</source><volume>24</volume>: <fpage>490</fpage>–<lpage>497</lpage><pub-id pub-id-type="pmid">21734245</pub-id></mixed-citation>
              </ref>
              <ref id="r6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>Puel</surname><given-names>A.</given-names></name><name><surname>Bonnet</surname><given-names>M.</given-names></name><name><surname>Ku</surname><given-names>C. L.</given-names></name><name><surname>Bustamante</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Soudais</surname><given-names>C.</given-names></name><name><surname>Dupuis</surname><given-names>S.</given-names></name><name><surname>Feinberg</surname><given-names>J.</given-names></name><name><surname>Fieschi</surname><given-names>C.</given-names></name><etal/></person-group>. <year>2003</year>. <article-title>Pyogenic bacterial infections in humans with IRAK-4 deficiency.</article-title><source>Science</source><volume>299</volume>: <fpage>2076</fpage>–<lpage>2079</lpage><pub-id pub-id-type="pmid">12637671</pub-id></mixed-citation>
              </ref>
              <ref id="r7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>T. W.</given-names></name><name><surname>Staschke</surname><given-names>K.</given-names></name><name><surname>Bulek</surname><given-names>K.</given-names></name><name><surname>Yao</surname><given-names>J.</given-names></name><name><surname>Peters</surname><given-names>K.</given-names></name><name><surname>Oh</surname><given-names>K. H.</given-names></name><name><surname>Vandenburg</surname><given-names>Y.</given-names></name><name><surname>Xiao</surname><given-names>H.</given-names></name><name><surname>Qian</surname><given-names>W.</given-names></name><name><surname>Hamilton</surname><given-names>T.</given-names></name><etal/></person-group>. <year>2007</year>. <article-title>A critical role for IRAK4 kinase activity in Toll-like receptor-mediated innate immunity.</article-title><source>J. Exp. Med.</source><volume>204</volume>: <fpage>1025</fpage>–<lpage>1036</lpage><pub-id pub-id-type="pmid">17470642</pub-id></mixed-citation>
              </ref>
              <ref id="r8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Bernuth</surname><given-names>H.</given-names></name><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>Puel</surname><given-names>A.</given-names></name><name><surname>Casanova</surname><given-names>J. L.</given-names></name></person-group>. <year>2012</year>. <article-title>Experimental and natural infections in MyD88- and IRAK-4-deficient mice and humans.</article-title><source>Eur. J. Immunol.</source><volume>42</volume>: <fpage>3126</fpage>–<lpage>3135</lpage><pub-id pub-id-type="pmid">23255009</pub-id></mixed-citation>
              </ref>
              <ref id="r9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>von Bernuth</surname><given-names>H.</given-names></name><name><surname>Ghandil</surname><given-names>P.</given-names></name><name><surname>Chrabieh</surname><given-names>M.</given-names></name><name><surname>Levy</surname><given-names>O.</given-names></name><name><surname>Arkwright</surname><given-names>P. D.</given-names></name><name><surname>McDonald</surname><given-names>D.</given-names></name><name><surname>Geha</surname><given-names>R. S.</given-names></name><name><surname>Takada</surname><given-names>H.</given-names></name><name><surname>Krause</surname><given-names>J. C.</given-names></name><etal/></person-group>. <year>2010</year>. <article-title>Clinical features and outcome of patients with IRAK-4 and MyD88 deficiency.</article-title><source>Medicine</source><volume>89</volume>: <fpage>403</fpage>–<lpage>425</lpage><pub-id pub-id-type="pmid">21057262</pub-id></mixed-citation>
              </ref>
              <ref id="r10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ku</surname><given-names>C. L.</given-names></name><name><surname>von Bernuth</surname><given-names>H.</given-names></name><name><surname>Picard</surname><given-names>C.</given-names></name><name><surname>Zhang</surname><given-names>S. Y.</given-names></name><name><surname>Chang</surname><given-names>H. H.</given-names></name><name><surname>Yang</surname><given-names>K.</given-names></name><name><surname>Chrabieh</surname><given-names>M.</given-names></name><name><surname>Issekutz</surname><given-names>A. C.</given-names></name><name><surname>Cunningham</surname><given-names>C. K.</given-names></name><name><surname>Gallin</surname><given-names>J.</given-names></name><etal/></person-group>. <year>2007</year>. <article-title>Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity.</article-title><source>J. Exp. Med.</source><volume>204</volume>: <fpage>2407</fpage>–<lpage>2422</lpage><pub-id pub-id-type="pmid">17893200</pub-id></mixed-citation>
              </ref>
              <ref id="r11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albiger</surname><given-names>B.</given-names></name><name><surname>Sandgren</surname><given-names>A.</given-names></name><name><surname>Katsuragi</surname><given-names>H.</given-names></name><name><surname>Meyer-Hoffert</surname><given-names>U.</given-names></name><name><surname>Beiter</surname><given-names>K.</given-names></name><name><surname>Wartha</surname><given-names>F.</given-names></name><name><surname>Hornef</surname><given-names>M.</given-names></name><name><surname>Normark</surname><given-names>S.</given-names></name><name><surname>Normark</surname><given-names>B. H.</given-names></name></person-group>. <year>2005</year>. <article-title>Myeloid differentiation factor 88-dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice.</article-title><source>Cell. Microbiol.</source><volume>7</volume>: <fpage>1603</fpage>–<lpage>1615</lpage><pub-id pub-id-type="pmid">16207247</pub-id></mixed-citation>
              </ref>
              <ref id="r12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koedel</surname><given-names>U.</given-names></name><name><surname>Rupprecht</surname><given-names>T.</given-names></name><name><surname>Angele</surname><given-names>B.</given-names></name><name><surname>Heesemann</surname><given-names>J.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Pfister</surname><given-names>H. W.</given-names></name><name><surname>Kirschning</surname><given-names>C. J.</given-names></name></person-group>. <year>2004</year>. <article-title>MyD88 is required for mounting a robust host immune response to <italic>Streptococcus pneumoniae</italic> in the CNS.</article-title><source>Brain</source><volume>127</volume>: <fpage>1437</fpage>–<lpage>1445</lpage><pub-id pub-id-type="pmid">15115715</pub-id></mixed-citation>
              </ref>
              <ref id="r13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>M. R.</given-names></name><name><surname>Simms</surname><given-names>B. T.</given-names></name><name><surname>Lupa</surname><given-names>M. M.</given-names></name><name><surname>Kogan</surname><given-names>M. S.</given-names></name><name><surname>Mizgerd</surname><given-names>J. P.</given-names></name></person-group>. <year>2005</year>. <article-title>Lung NF-kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia.</article-title><source>J. Immunol.</source><volume>175</volume>: <fpage>7530</fpage>–<lpage>7535</lpage><pub-id pub-id-type="pmid">16301661</pub-id></mixed-citation>
              </ref>
              <ref id="r14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zwijnenburg</surname><given-names>P. J.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name><name><surname>Florquin</surname><given-names>S.</given-names></name><name><surname>Roord</surname><given-names>J. J.</given-names></name><name><surname>Van Furth</surname><given-names>A. M.</given-names></name></person-group>. <year>2003</year>. <article-title>IL-1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis.</article-title><source>J. Immunol.</source><volume>170</volume>: <fpage>4724</fpage>–<lpage>4730</lpage><pub-id pub-id-type="pmid">12707352</pub-id></mixed-citation>
              </ref>
              <ref id="r15">
                <label>15</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wellmer</surname><given-names>A.</given-names></name><name><surname>Gerber</surname><given-names>J.</given-names></name><name><surname>Ragheb</surname><given-names>J.</given-names></name><name><surname>Zysk</surname><given-names>G.</given-names></name><name><surname>Kunst</surname><given-names>T.</given-names></name><name><surname>Smirnov</surname><given-names>A.</given-names></name><name><surname>Brück</surname><given-names>W.</given-names></name><name><surname>Nau</surname><given-names>R.</given-names></name></person-group>. <year>2001</year>. <article-title>Effect of deficiency of tumor necrosis factor alpha or both of its receptors on <italic>Streptococcus pneumoniae</italic> central nervous system infection and peritonitis.</article-title><source>Infect. Immun.</source><volume>69</volume>: <fpage>6881</fpage>–<lpage>6886</lpage><pub-id pub-id-type="pmid">11598062</pub-id></mixed-citation>
              </ref>
              <ref id="r16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malley</surname><given-names>R.</given-names></name><name><surname>Henneke</surname><given-names>P.</given-names></name><name><surname>Morse</surname><given-names>S. C.</given-names></name><name><surname>Cieslewicz</surname><given-names>M. J.</given-names></name><name><surname>Lipsitch</surname><given-names>M.</given-names></name><name><surname>Thompson</surname><given-names>C. M.</given-names></name><name><surname>Kurt-Jones</surname><given-names>E.</given-names></name><name><surname>Paton</surname><given-names>J. C.</given-names></name><name><surname>Wessels</surname><given-names>M. R.</given-names></name><name><surname>Golenbock</surname><given-names>D. T.</given-names></name></person-group>. <year>2003</year>. <article-title>Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection.</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>100</volume>: <fpage>1966</fpage>–<lpage>1971</lpage><pub-id pub-id-type="pmid">12569171</pub-id></mixed-citation>
              </ref>
              <ref id="r17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Albiger</surname><given-names>B.</given-names></name><name><surname>Dahlberg</surname><given-names>S.</given-names></name><name><surname>Sandgren</surname><given-names>A.</given-names></name><name><surname>Wartha</surname><given-names>F.</given-names></name><name><surname>Beiter</surname><given-names>K.</given-names></name><name><surname>Katsuragi</surname><given-names>H.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Normark</surname><given-names>S.</given-names></name><name><surname>Henriques-Normark</surname><given-names>B.</given-names></name></person-group>. <year>2007</year>. <article-title>Toll-like receptor 9 acts at an early stage in host defence against pneumococcal infection.</article-title><source>Cell. Microbiol.</source><volume>9</volume>: <fpage>633</fpage>–<lpage>644</lpage><pub-id pub-id-type="pmid">17004992</pub-id></mixed-citation>
              </ref>
              <ref id="r18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>S.</given-names></name><name><surname>Wieland</surname><given-names>C. W.</given-names></name><name><surname>van’t Veer</surname><given-names>C.</given-names></name><name><surname>Takeuchi</surname><given-names>O.</given-names></name><name><surname>Akira</surname><given-names>S.</given-names></name><name><surname>Florquin</surname><given-names>S.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name></person-group>. <year>2004</year>. <article-title>Toll-like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense.</article-title><source>J. Immunol.</source><volume>172</volume>: <fpage>3132</fpage>–<lpage>3138</lpage><pub-id pub-id-type="pmid">14978119</pub-id></mixed-citation>
              </ref>
              <ref id="r19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>A. Q.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Wu</surname><given-names>Z. Q.</given-names></name><name><surname>Paton</surname><given-names>J. C.</given-names></name><name><surname>Snapper</surname><given-names>C. M.</given-names></name></person-group>. <year>2005</year>. <article-title>Both innate immunity and type 1 humoral immunity to <italic>Streptococcus pneumoniae</italic> are mediated by MyD88 but differ in their relative levels of dependence on Toll-like receptor 2.</article-title><source>Infect. Immun.</source><volume>73</volume>: <fpage>298</fpage>–<lpage>307</lpage><pub-id pub-id-type="pmid">15618166</pub-id></mixed-citation>
              </ref>
              <ref id="r20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mogensen</surname><given-names>T. H.</given-names></name><name><surname>Paludan</surname><given-names>S. R.</given-names></name><name><surname>Kilian</surname><given-names>M.</given-names></name><name><surname>Ostergaard</surname><given-names>L.</given-names></name></person-group>. <year>2006</year>. <article-title>Live <italic>Streptococcus pneumoniae</italic>, <italic>Haemophilus influenzae</italic>, and <italic>Neisseria meningitidis</italic> activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns.</article-title><source>J. Leukoc. Biol.</source><volume>80</volume>: <fpage>267</fpage>–<lpage>277</lpage><pub-id pub-id-type="pmid">16731773</pub-id></mixed-citation>
              </ref>
              <ref id="r21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>K. S.</given-names></name><name><surname>Scanga</surname><given-names>C. A.</given-names></name><name><surname>Bachelder</surname><given-names>E. M.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Snapper</surname><given-names>C. M.</given-names></name></person-group>. <year>2007</year>. <article-title>TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to <italic>Streptococcus pneumoniae.</italic></article-title><source>Cell. Immunol.</source><volume>245</volume>: <fpage>103</fpage>–<lpage>110</lpage><pub-id pub-id-type="pmid">17521621</pub-id></mixed-citation>
              </ref>
              <ref id="r22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessing</surname><given-names>M. C.</given-names></name><name><surname>Florquin</surname><given-names>S.</given-names></name><name><surname>Paton</surname><given-names>J. C.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name></person-group>. <year>2008</year>. <article-title>Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci.</article-title><source>Cell. Microbiol.</source><volume>10</volume>: <fpage>237</fpage>–<lpage>246</lpage><pub-id pub-id-type="pmid">17711480</pub-id></mixed-citation>
              </ref>
              <ref id="r23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>M.</given-names></name><name><surname>Obermaier</surname><given-names>B.</given-names></name><name><surname>Angele</surname><given-names>B.</given-names></name><name><surname>Pfister</surname><given-names>H. W.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Koedel</surname><given-names>U.</given-names></name><name><surname>Kirschning</surname><given-names>C. J.</given-names></name></person-group>. <year>2008</year>. <article-title>Innate immunity to pneumococcal infection of the central nervous system depends on Toll-like receptor (TLR) 2 and TLR4.</article-title><source>J. Infect. Dis.</source><volume>198</volume>: <fpage>1028</fpage>–<lpage>1036</lpage><pub-id pub-id-type="pmid">18700834</pub-id></mixed-citation>
              </ref>
              <ref id="r24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koedel</surname><given-names>U.</given-names></name><name><surname>Angele</surname><given-names>B.</given-names></name><name><surname>Rupprecht</surname><given-names>T.</given-names></name><name><surname>Wagner</surname><given-names>H.</given-names></name><name><surname>Roggenkamp</surname><given-names>A.</given-names></name><name><surname>Pfister</surname><given-names>H. W.</given-names></name><name><surname>Kirschning</surname><given-names>C. J.</given-names></name></person-group>. <year>2003</year>. <article-title>Toll-like receptor 2 participates in mediation of immune response in experimental pneumococcal meningitis.</article-title><source>J. Immunol.</source><volume>170</volume>: <fpage>438</fpage>–<lpage>444</lpage><pub-id pub-id-type="pmid">12496429</pub-id></mixed-citation>
              </ref>
              <ref id="r25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreira</surname><given-names>L. O.</given-names></name><name><surname>El Kasmi</surname><given-names>K. C.</given-names></name><name><surname>Smith</surname><given-names>A. M.</given-names></name><name><surname>Finkelstein</surname><given-names>D.</given-names></name><name><surname>Fillon</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>Y. G.</given-names></name><name><surname>Núñez</surname><given-names>G.</given-names></name><name><surname>Tuomanen</surname><given-names>E.</given-names></name><name><surname>Murray</surname><given-names>P. J.</given-names></name></person-group>. <year>2008</year>. <article-title>The TLR2-MyD88-NOD2-RIPK2 signalling axis regulates a balanced pro-inflammatory and IL-10-mediated anti-inflammatory cytokine response to Gram-positive cell walls.</article-title><source>Cell. Microbiol.</source><volume>10</volume>: <fpage>2067</fpage>–<lpage>2077</lpage><pub-id pub-id-type="pmid">18549453</pub-id></mixed-citation>
              </ref>
              <ref id="r26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dessing</surname><given-names>M. C.</given-names></name><name><surname>Hirst</surname><given-names>R. A.</given-names></name><name><surname>de Vos</surname><given-names>A. F.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name></person-group>. <year>2009</year>. <article-title>Role of Toll-like receptors 2 and 4 in pulmonary inflammation and injury induced by pneumolysin in mice.</article-title><source>PLoS One</source><volume>4</volume>: <fpage>e7993</fpage><pub-id pub-id-type="pmid">19956717</pub-id></mixed-citation>
              </ref>
              <ref id="r27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McNeela</surname><given-names>E. A.</given-names></name><name><surname>Burke</surname><given-names>A.</given-names></name><name><surname>Neill</surname><given-names>D. R.</given-names></name><name><surname>Baxter</surname><given-names>C.</given-names></name><name><surname>Fernandes</surname><given-names>V. E.</given-names></name><name><surname>Ferreira</surname><given-names>D.</given-names></name><name><surname>Smeaton</surname><given-names>S.</given-names></name><name><surname>El-Rachkidy</surname><given-names>R.</given-names></name><name><surname>McLoughlin</surname><given-names>R. M.</given-names></name><name><surname>Mori</surname><given-names>A.</given-names></name><etal/></person-group>. <year>2010</year>. <article-title>Pneumolysin activates the NLRP3 inflammasome and promotes proinflammatory cytokines independently of TLR4.</article-title><source>PLoS Pathog.</source><volume>6</volume>: <fpage>e1001191</fpage><pub-id pub-id-type="pmid">21085613</pub-id></mixed-citation>
              </ref>
              <ref id="r28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Z.</given-names></name><name><surname>Clarke</surname><given-names>T. B.</given-names></name><name><surname>Weiser</surname><given-names>J. N.</given-names></name></person-group>. <year>2009</year>. <article-title>Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice.</article-title><source>J. Clin. Invest.</source><volume>119</volume>: <fpage>1899</fpage>–<lpage>1909</lpage><pub-id pub-id-type="pmid">19509469</pub-id></mixed-citation>
              </ref>
              <ref id="r29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname><given-names>G.</given-names></name><name><surname>Khan</surname><given-names>A. Q.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Snapper</surname><given-names>C. M.</given-names></name></person-group>. <year>2005</year>. <article-title>In vivo humoral immune responses to isolated pneumococcal polysaccharides are dependent on the presence of associated TLR ligands.</article-title><source>J. Immunol.</source><volume>175</volume>: <fpage>3084</fpage>–<lpage>3091</lpage><pub-id pub-id-type="pmid">16116197</pub-id></mixed-citation>
              </ref>
              <ref id="r30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clarke</surname><given-names>T. B.</given-names></name><name><surname>Francella</surname><given-names>N.</given-names></name><name><surname>Huegel</surname><given-names>A.</given-names></name><name><surname>Weiser</surname><given-names>J. N.</given-names></name></person-group>. <year>2011</year>. <article-title>Invasive bacterial pathogens exploit TLR-mediated downregulation of tight junction components to facilitate translocation across the epithelium.</article-title><source>Cell Host Microbe</source><volume>9</volume>: <fpage>404</fpage>–<lpage>414</lpage><pub-id pub-id-type="pmid">21575911</pub-id></mixed-citation>
              </ref>
              <ref id="r31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draing</surname><given-names>C.</given-names></name><name><surname>Sigel</surname><given-names>S.</given-names></name><name><surname>Deininger</surname><given-names>S.</given-names></name><name><surname>Traub</surname><given-names>S.</given-names></name><name><surname>Munke</surname><given-names>R.</given-names></name><name><surname>Mayer</surname><given-names>C.</given-names></name><name><surname>Hareng</surname><given-names>L.</given-names></name><name><surname>Hartung</surname><given-names>T.</given-names></name><name><surname>von Aulock</surname><given-names>S.</given-names></name><name><surname>Hermann</surname><given-names>C.</given-names></name></person-group>. <year>2008</year>. <article-title>Cytokine induction by Gram-positive bacteria.</article-title><source>Immunobiology</source><volume>213</volume>: <fpage>285</fpage>–<lpage>296</lpage><pub-id pub-id-type="pmid">18406374</pub-id></mixed-citation>
              </ref>
              <ref id="r32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zähringer</surname><given-names>U.</given-names></name><name><surname>Lindner</surname><given-names>B.</given-names></name><name><surname>Inamura</surname><given-names>S.</given-names></name><name><surname>Heine</surname><given-names>H.</given-names></name><name><surname>Alexander</surname><given-names>C.</given-names></name></person-group>. <year>2008</year>. <article-title>TLR2—promiscuous or specific? A critical re-evaluation of a receptor expressing apparent broad specificity.</article-title><source>Immunobiology</source><volume>213</volume>: <fpage>205</fpage>–<lpage>224</lpage><pub-id pub-id-type="pmid">18406368</pub-id></mixed-citation>
              </ref>
              <ref id="r33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Draing</surname><given-names>C.</given-names></name><name><surname>Pfitzenmaier</surname><given-names>M.</given-names></name><name><surname>Zummo</surname><given-names>S.</given-names></name><name><surname>Mancuso</surname><given-names>G.</given-names></name><name><surname>Geyer</surname><given-names>A.</given-names></name><name><surname>Hartung</surname><given-names>T.</given-names></name><name><surname>von Aulock</surname><given-names>S.</given-names></name></person-group>. <year>2006</year>. <article-title>Comparison of lipoteichoic acid from different serotypes of <italic>Streptococcus pneumoniae.</italic></article-title><source>J. Biol. Chem.</source><volume>281</volume>: <fpage>33849</fpage>–<lpage>33859</lpage><pub-id pub-id-type="pmid">16943191</pub-id></mixed-citation>
              </ref>
              <ref id="r34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuomanen</surname><given-names>E.</given-names></name><name><surname>Rich</surname><given-names>R.</given-names></name><name><surname>Zak</surname><given-names>O.</given-names></name></person-group>. <year>1987</year>. <article-title>Induction of pulmonary inflammation by components of the pneumococcal cell surface.</article-title><source>Am. Rev. Respir. Dis.</source><volume>135</volume>: <fpage>869</fpage>–<lpage>874</lpage><pub-id pub-id-type="pmid">3565933</pub-id></mixed-citation>
              </ref>
              <ref id="r35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hanisch</surname><given-names>U. K.</given-names></name><name><surname>Prinz</surname><given-names>M.</given-names></name><name><surname>Angstwurm</surname><given-names>K.</given-names></name><name><surname>Häusler</surname><given-names>K. G.</given-names></name><name><surname>Kann</surname><given-names>O.</given-names></name><name><surname>Kettenmann</surname><given-names>H.</given-names></name><name><surname>Weber</surname><given-names>J. R.</given-names></name></person-group>. <year>2001</year>. <article-title>The protein tyrosine kinase inhibitor AG126 prevents the massive microglial cytokine induction by pneumococcal cell walls.</article-title><source>Eur. J. Immunol.</source><volume>31</volume>: <fpage>2104</fpage>–<lpage>2115</lpage><pub-id pub-id-type="pmid">11449364</pub-id></mixed-citation>
              </ref>
              <ref id="r36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davis</surname><given-names>K. M.</given-names></name><name><surname>Nakamura</surname><given-names>S.</given-names></name><name><surname>Weiser</surname><given-names>J. N.</given-names></name></person-group>. <year>2011</year>. <article-title>Nod2 sensing of lysozyme-digested peptidoglycan promotes macrophage recruitment and clearance of <italic>S. pneumoniae</italic> colonization in mice.</article-title><source>J. Clin. Invest.</source><volume>121</volume>: <fpage>3666</fpage>–<lpage>3676</lpage><pub-id pub-id-type="pmid">21841315</pub-id></mixed-citation>
              </ref>
              <ref id="r37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Opitz</surname><given-names>B.</given-names></name><name><surname>Püschel</surname><given-names>A.</given-names></name><name><surname>Schmeck</surname><given-names>B.</given-names></name><name><surname>Hocke</surname><given-names>A. C.</given-names></name><name><surname>Rosseau</surname><given-names>S.</given-names></name><name><surname>Hammerschmidt</surname><given-names>S.</given-names></name><name><surname>Schumann</surname><given-names>R. R.</given-names></name><name><surname>Suttorp</surname><given-names>N.</given-names></name><name><surname>Hippenstiel</surname><given-names>S.</given-names></name></person-group>. <year>2004</year>. <article-title>Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized <italic>Streptococcus pneumoniae.</italic></article-title><source>J. Biol. Chem.</source><volume>279</volume>: <fpage>36426</fpage>–<lpage>36432</lpage><pub-id pub-id-type="pmid">15215247</pub-id></mixed-citation>
              </ref>
              <ref id="r38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gisch</surname><given-names>N.</given-names></name><name><surname>Kohler</surname><given-names>T.</given-names></name><name><surname>Ulmer</surname><given-names>A. J.</given-names></name><name><surname>Müthing</surname><given-names>J.</given-names></name><name><surname>Pribyl</surname><given-names>T.</given-names></name><name><surname>Fischer</surname><given-names>K.</given-names></name><name><surname>Lindner</surname><given-names>B.</given-names></name><name><surname>Hammerschmidt</surname><given-names>S.</given-names></name><name><surname>Zähringer</surname><given-names>U.</given-names></name></person-group>. <year>2013</year>. <article-title>Structural reevaluation of <italic>Streptococcus pneumoniae</italic> lipoteichoic acid and new insights into its immunostimulatory potency.</article-title><source>J. Biol. Chem.</source><volume>288</volume>: <fpage>15654</fpage>–<lpage>15667</lpage><pub-id pub-id-type="pmid">23603911</pub-id></mixed-citation>
              </ref>
              <ref id="r39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stoll</surname><given-names>H.</given-names></name><name><surname>Dengjel</surname><given-names>J.</given-names></name><name><surname>Nerz</surname><given-names>C.</given-names></name><name><surname>Götz</surname><given-names>F.</given-names></name></person-group>. <year>2005</year>. <article-title><italic>Staphylococcus aureus</italic> deficient in lipidation of prelipoproteins is attenuated in growth and immune activation.</article-title><source>Infect. Immun.</source><volume>73</volume>: <fpage>2411</fpage>–<lpage>2423</lpage><pub-id pub-id-type="pmid">15784587</pub-id></mixed-citation>
              </ref>
              <ref id="r40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hashimoto</surname><given-names>M.</given-names></name><name><surname>Tawaratsumida</surname><given-names>K.</given-names></name><name><surname>Kariya</surname><given-names>H.</given-names></name><name><surname>Kiyohara</surname><given-names>A.</given-names></name><name><surname>Suda</surname><given-names>Y.</given-names></name><name><surname>Krikae</surname><given-names>F.</given-names></name><name><surname>Kirikae</surname><given-names>T.</given-names></name><name><surname>Götz</surname><given-names>F.</given-names></name></person-group>. <year>2006</year>. <article-title>Not lipoteichoic acid but lipoproteins appear to be the dominant immunobiologically active compounds in <italic>Staphylococcus aureus.</italic></article-title><source>J. Immunol.</source><volume>177</volume>: <fpage>3162</fpage>–<lpage>3169</lpage><pub-id pub-id-type="pmid">16920954</pub-id></mixed-citation>
              </ref>
              <ref id="r41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tseng</surname><given-names>H. J.</given-names></name><name><surname>McEwan</surname><given-names>A. G.</given-names></name><name><surname>Paton</surname><given-names>J. C.</given-names></name><name><surname>Jennings</surname><given-names>M. P.</given-names></name></person-group>. <year>2002</year>. <article-title>Virulence of <italic>Streptococcus pneumoniae</italic>: PsaA mutants are hypersensitive to oxidative stress.</article-title><source>Infect. Immun.</source><volume>70</volume>: <fpage>1635</fpage>–<lpage>1639</lpage><pub-id pub-id-type="pmid">11854257</pub-id></mixed-citation>
              </ref>
              <ref id="r42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderton</surname><given-names>J. M.</given-names></name><name><surname>Rajam</surname><given-names>G.</given-names></name><name><surname>Romero-Steiner</surname><given-names>S.</given-names></name><name><surname>Summer</surname><given-names>S.</given-names></name><name><surname>Kowalczyk</surname><given-names>A. P.</given-names></name><name><surname>Carlone</surname><given-names>G. M.</given-names></name><name><surname>Sampson</surname><given-names>J. S.</given-names></name><name><surname>Ades</surname><given-names>E. W.</given-names></name></person-group>. <year>2007</year>. <article-title>E-cadherin is a receptor for the common protein pneumococcal surface adhesin A (PsaA) of <italic>Streptococcus pneumoniae.</italic></article-title><source>Microb. Pathog.</source><volume>42</volume>: <fpage>225</fpage>–<lpage>236</lpage><pub-id pub-id-type="pmid">17412553</pub-id></mixed-citation>
              </ref>
              <ref id="r43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Basavanna</surname><given-names>S.</given-names></name><name><surname>Khandavilli</surname><given-names>S.</given-names></name><name><surname>Yuste</surname><given-names>J.</given-names></name><name><surname>Cohen</surname><given-names>J. M.</given-names></name><name><surname>Hosie</surname><given-names>A. H.</given-names></name><name><surname>Webb</surname><given-names>A. J.</given-names></name><name><surname>Thomas</surname><given-names>G. H.</given-names></name><name><surname>Brown</surname><given-names>J. S.</given-names></name></person-group>. <year>2009</year>. <article-title>Screening of <italic>Streptococcus pneumoniae</italic> ABC transporter mutants demonstrates that LivJHMGF, a branched-chain amino acid ABC transporter, is necessary for disease pathogenesis.</article-title><source>Infect. Immun.</source><volume>77</volume>: <fpage>3412</fpage>–<lpage>3423</lpage><pub-id pub-id-type="pmid">19470745</pub-id></mixed-citation>
              </ref>
              <ref id="r44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>J. S.</given-names></name><name><surname>Gilliland</surname><given-names>S. M.</given-names></name><name><surname>Holden</surname><given-names>D. W.</given-names></name></person-group>. <year>2001</year>. <article-title>A <italic>Streptococcus pneumoniae</italic> pathogenicity island encoding an ABC transporter involved in iron uptake and virulence.</article-title><source>Mol. Microbiol.</source><volume>40</volume>: <fpage>572</fpage>–<lpage>585</lpage><pub-id pub-id-type="pmid">11359564</pub-id></mixed-citation>
              </ref>
              <ref id="r45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimalapati</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>J. M.</given-names></name><name><surname>Camberlein</surname><given-names>E.</given-names></name><name><surname>MacDonald</surname><given-names>N.</given-names></name><name><surname>Durmort</surname><given-names>C.</given-names></name><name><surname>Vernet</surname><given-names>T.</given-names></name><name><surname>Hermans</surname><given-names>P. W.</given-names></name><name><surname>Mitchell</surname><given-names>T.</given-names></name><name><surname>Brown</surname><given-names>J. S.</given-names></name></person-group>. <year>2012</year>. <article-title>Effects of deletion of the <italic>Streptococcus pneumoniae</italic> lipoprotein diacylglyceryl transferase gene lgt on ABC transporter function and on growth in vivo.</article-title><source>PLoS One</source><volume>7</volume>: <fpage>e41393</fpage><pub-id pub-id-type="pmid">22911788</pub-id></mixed-citation>
              </ref>
              <ref id="r46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bayle</surname><given-names>L.</given-names></name><name><surname>Chimalapati</surname><given-names>S.</given-names></name><name><surname>Schoehn</surname><given-names>G.</given-names></name><name><surname>Brown</surname><given-names>J.</given-names></name><name><surname>Vernet</surname><given-names>T.</given-names></name><name><surname>Durmort</surname><given-names>C.</given-names></name></person-group>. <year>2011</year>. <article-title>Zinc uptake by <italic>Streptococcus pneumoniae</italic> depends on both AdcA and AdcAII and is essential for normal bacterial morphology and virulence.</article-title><source>Mol. Microbiol.</source><volume>82</volume>: <fpage>904</fpage>–<lpage>916</lpage><pub-id pub-id-type="pmid">22023106</pub-id></mixed-citation>
              </ref>
              <ref id="r47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimalapati</surname><given-names>S.</given-names></name><name><surname>Cohen</surname><given-names>J.</given-names></name><name><surname>Camberlein</surname><given-names>E.</given-names></name><name><surname>Durmort</surname><given-names>C.</given-names></name><name><surname>Baxendale</surname><given-names>H.</given-names></name><name><surname>de Vogel</surname><given-names>C.</given-names></name><name><surname>van Belkum</surname><given-names>A.</given-names></name><name><surname>Brown</surname><given-names>J. S.</given-names></name></person-group>. <year>2011</year>. <article-title>Infection with conditionally virulent <italic>Streptococcus pneumoniae</italic> Δpab strains induces antibody to conserved protein antigens but does not protect against systemic infection with heterologous strains.</article-title><source>Infect. Immun.</source><volume>79</volume>: <fpage>4965</fpage>–<lpage>4976</lpage><pub-id pub-id-type="pmid">21947774</pub-id></mixed-citation>
              </ref>
              <ref id="r48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bordier</surname><given-names>C.</given-names></name></person-group><year>1981</year>. <article-title>Phase separation of integral membrane proteins in Triton X-114 solution.</article-title><source>J. Biol. Chem.</source><volume>256</volume>: <fpage>1604</fpage>–<lpage>1607</lpage><pub-id pub-id-type="pmid">6257680</pub-id></mixed-citation>
              </ref>
              <ref id="r49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khandavilli</surname><given-names>S.</given-names></name><name><surname>Homer</surname><given-names>K. A.</given-names></name><name><surname>Yuste</surname><given-names>J.</given-names></name><name><surname>Basavanna</surname><given-names>S.</given-names></name><name><surname>Mitchell</surname><given-names>T.</given-names></name><name><surname>Brown</surname><given-names>J. S.</given-names></name></person-group>. <year>2008</year>. <article-title>Maturation of <italic>Streptococcus pneumoniae</italic> lipoproteins by a type II signal peptidase is required for ABC transporter function and full virulence.</article-title><source>Mol. Microbiol.</source><volume>67</volume>: <fpage>541</fpage>–<lpage>557</lpage><pub-id pub-id-type="pmid">18086214</pub-id></mixed-citation>
              </ref>
              <ref id="r50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsang</surname><given-names>J.</given-names></name><name><surname>Chain</surname><given-names>B. M.</given-names></name><name><surname>Miller</surname><given-names>R. F.</given-names></name><name><surname>Webb</surname><given-names>B. L.</given-names></name><name><surname>Barclay</surname><given-names>W.</given-names></name><name><surname>Towers</surname><given-names>G. J.</given-names></name><name><surname>Katz</surname><given-names>D. R.</given-names></name><name><surname>Noursadeghi</surname><given-names>M.</given-names></name></person-group>. <year>2009</year>. <article-title>HIV-1 infection of macrophages is dependent on evasion of innate immune cellular activation.</article-title><source>AIDS</source><volume>23</volume>: <fpage>2255</fpage>–<lpage>2263</lpage><pub-id pub-id-type="pmid">19741482</pub-id></mixed-citation>
              </ref>
              <ref id="r51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Machata</surname><given-names>S.</given-names></name><name><surname>Tchatalbachev</surname><given-names>S.</given-names></name><name><surname>Mohamed</surname><given-names>W.</given-names></name><name><surname>Jänsch</surname><given-names>L.</given-names></name><name><surname>Hain</surname><given-names>T.</given-names></name><name><surname>Chakraborty</surname><given-names>T.</given-names></name></person-group>. <year>2008</year>. <article-title>Lipoproteins of <italic>Listeria monocytogenes</italic> are critical for virulence and TLR2-mediated immune activation.</article-title><source>J. Immunol.</source><volume>181</volume>: <fpage>2028</fpage>–<lpage>2035</lpage><pub-id pub-id-type="pmid">18641340</pub-id></mixed-citation>
              </ref>
              <ref id="r52">
                <label>52</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X.</given-names></name><name><surname>Goncalves</surname><given-names>R.</given-names></name><name><surname>Mosser</surname><given-names>D. M.</given-names></name></person-group>. <year>2008</year>. <comment><italic>The isolation and characterization of murine macrophages.</italic> Curr. Protoc. Immunol. Chapter 14: Unit 14.1.</comment></mixed-citation>
              </ref>
              <ref id="r53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>N. K.</given-names></name><name><surname>Eberhardt</surname><given-names>A.</given-names></name><name><surname>Vollmer</surname><given-names>D.</given-names></name><name><surname>Kern</surname><given-names>T.</given-names></name><name><surname>Bougault</surname><given-names>C.</given-names></name><name><surname>Tomasz</surname><given-names>A.</given-names></name><name><surname>Simorre</surname><given-names>J. P.</given-names></name><name><surname>Vollmer</surname><given-names>W.</given-names></name></person-group>. <year>2012</year>. <article-title>Isolation and analysis of cell wall components from <italic>Streptococcus pneumoniae.</italic></article-title><source>Anal. Biochem.</source><volume>421</volume>: <fpage>657</fpage>–<lpage>666</lpage><pub-id pub-id-type="pmid">22192687</pub-id></mixed-citation>
              </ref>
              <ref id="r54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bui</surname><given-names>N. K.</given-names></name><name><surname>Gray</surname><given-names>J.</given-names></name><name><surname>Schwarz</surname><given-names>H.</given-names></name><name><surname>Schumann</surname><given-names>P.</given-names></name><name><surname>Blanot</surname><given-names>D.</given-names></name><name><surname>Vollmer</surname><given-names>W.</given-names></name></person-group>. <year>2009</year>. <article-title>The peptidoglycan sacculus of <italic>Myxococcus xanthus</italic> has unusual structural features and is degraded during glycerol-induced myxospore development.</article-title><source>J. Bacteriol.</source><volume>191</volume>: <fpage>494</fpage>–<lpage>505</lpage><pub-id pub-id-type="pmid">18996994</pub-id></mixed-citation>
              </ref>
              <ref id="r55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Noursadeghi</surname><given-names>M.</given-names></name><name><surname>Tsang</surname><given-names>J.</given-names></name><name><surname>Haustein</surname><given-names>T.</given-names></name><name><surname>Miller</surname><given-names>R. F.</given-names></name><name><surname>Chain</surname><given-names>B. M.</given-names></name><name><surname>Katz</surname><given-names>D. R.</given-names></name></person-group>. <year>2008</year>. <article-title>Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages.</article-title><source>J. Immunol. Methods</source><volume>329</volume>: <fpage>194</fpage>–<lpage>200</lpage><pub-id pub-id-type="pmid">18036607</pub-id></mixed-citation>
              </ref>
              <ref id="r56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chain</surname><given-names>B.</given-names></name><name><surname>Bowen</surname><given-names>H.</given-names></name><name><surname>Hammond</surname><given-names>J.</given-names></name><name><surname>Posch</surname><given-names>W.</given-names></name><name><surname>Rasaiyaah</surname><given-names>J.</given-names></name><name><surname>Tsang</surname><given-names>J.</given-names></name><name><surname>Noursadeghi</surname><given-names>M.</given-names></name></person-group>. <year>2010</year>. <article-title>Error, reproducibility and sensitivity: a pipeline for data processing of Agilent oligonucleotide expression arrays.</article-title><source>BMC Bioinformatics</source><volume>11</volume>: <fpage>344</fpage><pub-id pub-id-type="pmid">20576120</pub-id></mixed-citation>
              </ref>
              <ref id="r57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tomlinson</surname><given-names>G. S.</given-names></name><name><surname>Cashmore</surname><given-names>T. J.</given-names></name><name><surname>Elkington</surname><given-names>P. T.</given-names></name><name><surname>Yates</surname><given-names>J.</given-names></name><name><surname>Lehloenya</surname><given-names>R. J.</given-names></name><name><surname>Tsang</surname><given-names>J.</given-names></name><name><surname>Brown</surname><given-names>M.</given-names></name><name><surname>Miller</surname><given-names>R. F.</given-names></name><name><surname>Dheda</surname><given-names>K.</given-names></name><name><surname>Katz</surname><given-names>D. R.</given-names></name><etal/></person-group>. <year>2011</year>. <article-title>Transcriptional profiling of innate and adaptive human immune responses to mycobacteria in the tuberculin skin test.</article-title><source>Eur. J. Immunol.</source><volume>41</volume>: <fpage>3253</fpage>–<lpage>3260</lpage><pub-id pub-id-type="pmid">21805471</pub-id></mixed-citation>
              </ref>
              <ref id="r58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vollmer</surname><given-names>W.</given-names></name><name><surname>Tomasz</surname><given-names>A.</given-names></name></person-group>. <year>2000</year>. <article-title>The pgdA gene encodes for a peptidoglycan N-acetylglucosamine deacetylase in <italic>Streptococcus pneumoniae.</italic></article-title><source>J. Biol. Chem.</source><volume>275</volume>: <fpage>20496</fpage>–<lpage>20501</lpage><pub-id pub-id-type="pmid">10781617</pub-id></mixed-citation>
              </ref>
              <ref id="r59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amory-Rivier</surname><given-names>C. F.</given-names></name><name><surname>Mohler</surname><given-names>J.</given-names></name><name><surname>Bédos</surname><given-names>J. P.</given-names></name><name><surname>Azoulay-Dupuis</surname><given-names>E.</given-names></name><name><surname>Henin</surname><given-names>D.</given-names></name><name><surname>Muffat-Joly</surname><given-names>M.</given-names></name><name><surname>Carbon</surname><given-names>C.</given-names></name><name><surname>Moine</surname><given-names>P.</given-names></name></person-group>. <year>2000</year>. <article-title>Nuclear factor-kappaB activation in mouse lung lavage cells in response to <italic>Streptococcus pneumoniae</italic> pulmonary infection.</article-title><source>Crit. Care Med.</source><volume>28</volume>: <fpage>3249</fpage>–<lpage>3256</lpage><pub-id pub-id-type="pmid">11008989</pub-id></mixed-citation>
              </ref>
              <ref id="r60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pittet</surname><given-names>L. A.</given-names></name><name><surname>Quinton</surname><given-names>L. J.</given-names></name><name><surname>Yamamoto</surname><given-names>K.</given-names></name><name><surname>Robson</surname><given-names>B. E.</given-names></name><name><surname>Ferrari</surname><given-names>J. D.</given-names></name><name><surname>Algül</surname><given-names>H.</given-names></name><name><surname>Schmid</surname><given-names>R. M.</given-names></name><name><surname>Mizgerd</surname><given-names>J. P.</given-names></name></person-group>. <year>2011</year>. <article-title>Earliest innate immune responses require macrophage RelA during pneumococcal pneumonia.</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><volume>45</volume>: <fpage>573</fpage>–<lpage>581</lpage><pub-id pub-id-type="pmid">21216972</pub-id></mixed-citation>
              </ref>
              <ref id="r61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knapp</surname><given-names>S.</given-names></name><name><surname>von Aulock</surname><given-names>S.</given-names></name><name><surname>Leendertse</surname><given-names>M.</given-names></name><name><surname>Haslinger</surname><given-names>I.</given-names></name><name><surname>Draing</surname><given-names>C.</given-names></name><name><surname>Golenbock</surname><given-names>D. T.</given-names></name><name><surname>van der Poll</surname><given-names>T.</given-names></name></person-group>. <year>2008</year>. <article-title>Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor.</article-title><source>J. Immunol.</source><volume>180</volume>: <fpage>3478</fpage>–<lpage>3484</lpage><pub-id pub-id-type="pmid">18292574</pub-id></mixed-citation>
              </ref>
              <ref id="r62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tuomanen</surname><given-names>E.</given-names></name><name><surname>Tomasz</surname><given-names>A.</given-names></name><name><surname>Hengstler</surname><given-names>B.</given-names></name><name><surname>Zak</surname><given-names>O.</given-names></name></person-group>. <year>1985</year>. <article-title>The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis.</article-title><source>J. Infect. Dis.</source><volume>151</volume>: <fpage>535</fpage>–<lpage>540</lpage><pub-id pub-id-type="pmid">3973407</pub-id></mixed-citation>
              </ref>
              <ref id="r63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jagger</surname><given-names>M. P.</given-names></name><name><surname>Huo</surname><given-names>Z.</given-names></name><name><surname>Riches</surname><given-names>P. G.</given-names></name></person-group>. <year>2002</year>. <article-title>Inflammatory cytokine (interleukin 6 and tumour necrosis factor alpha) release in a human whole blood system in response to <italic>Streptococcus pneumoniae</italic> serotype 14 and its capsular polysaccharide.</article-title><source>Clin. Exp. Immunol.</source><volume>130</volume>: <fpage>467</fpage>–<lpage>474</lpage><pub-id pub-id-type="pmid">12452837</pub-id></mixed-citation>
              </ref>
              <ref id="r64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>S. Q.</given-names></name><name><surname>Singh</surname><given-names>R.</given-names></name><name><surname>Bice</surname><given-names>D. E.</given-names></name></person-group>. <year>1994</year>. <article-title>Heat-killed pneumococci and pneumococcal capsular polysaccharides stimulate tumor necrosis factor-alpha production by murine macrophages.</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><volume>10</volume>: <fpage>284</fpage>–<lpage>289</lpage><pub-id pub-id-type="pmid">8117447</pub-id></mixed-citation>
              </ref>
              <ref id="r65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henneke</surname><given-names>P.</given-names></name><name><surname>Dramsi</surname><given-names>S.</given-names></name><name><surname>Mancuso</surname><given-names>G.</given-names></name><name><surname>Chraibi</surname><given-names>K.</given-names></name><name><surname>Pellegrini</surname><given-names>E.</given-names></name><name><surname>Theilacker</surname><given-names>C.</given-names></name><name><surname>Hübner</surname><given-names>J.</given-names></name><name><surname>Santos-Sierra</surname><given-names>S.</given-names></name><name><surname>Teti</surname><given-names>G.</given-names></name><name><surname>Golenbock</surname><given-names>D. T.</given-names></name><etal/></person-group>. <year>2008</year>. <article-title>Lipoproteins are critical TLR2 activating toxins in group B streptococcal sepsis.</article-title><source>J. Immunol.</source><volume>180</volume>: <fpage>6149</fpage>–<lpage>6158</lpage><pub-id pub-id-type="pmid">18424736</pub-id></mixed-citation>
              </ref>
              <ref id="r66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shoma</surname><given-names>S.</given-names></name><name><surname>Tsuchiya</surname><given-names>K.</given-names></name><name><surname>Kawamura</surname><given-names>I.</given-names></name><name><surname>Nomura</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>H.</given-names></name><name><surname>Uchiyama</surname><given-names>R.</given-names></name><name><surname>Daim</surname><given-names>S.</given-names></name><name><surname>Mitsuyama</surname><given-names>M.</given-names></name></person-group>. <year>2008</year>. <article-title>Critical involvement of pneumolysin in production of interleukin-1alpha and caspase-1-dependent cytokines in infection with <italic>Streptococcus pneumoniae</italic> in vitro: a novel function of pneumolysin in caspase-1 activation.</article-title><source>Infect. Immun.</source><volume>76</volume>: <fpage>1547</fpage>–<lpage>1557</lpage><pub-id pub-id-type="pmid">18195026</pub-id></mixed-citation>
              </ref>
              <ref id="r67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Witzenrath</surname><given-names>M.</given-names></name><name><surname>Pache</surname><given-names>F.</given-names></name><name><surname>Lorenz</surname><given-names>D.</given-names></name><name><surname>Koppe</surname><given-names>U.</given-names></name><name><surname>Gutbier</surname><given-names>B.</given-names></name><name><surname>Tabeling</surname><given-names>C.</given-names></name><name><surname>Reppe</surname><given-names>K.</given-names></name><name><surname>Meixenberger</surname><given-names>K.</given-names></name><name><surname>Dorhoi</surname><given-names>A.</given-names></name><name><surname>Ma</surname><given-names>J.</given-names></name><etal/></person-group>. <year>2011</year>. <article-title>The NLRP3 inflammasome is differentially activated by pneumolysin variants and contributes to host defense in pneumococcal pneumonia.</article-title><source>J. Immunol.</source><volume>187</volume>: <fpage>434</fpage>–<lpage>440</lpage><pub-id pub-id-type="pmid">21646297</pub-id></mixed-citation>
              </ref>
              <ref id="r68">
                <label>68</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rogers</surname><given-names>P. D.</given-names></name><name><surname>Thornton</surname><given-names>J.</given-names></name><name><surname>Barker</surname><given-names>K. S.</given-names></name><name><surname>McDaniel</surname><given-names>D. O.</given-names></name><name><surname>Sacks</surname><given-names>G. S.</given-names></name><name><surname>Swiatlo</surname><given-names>E.</given-names></name><name><surname>McDaniel</surname><given-names>L. S.</given-names></name></person-group>. <year>2003</year>. <article-title>Pneumolysin-dependent and -independent gene expression identified by cDNA microarray analysis of THP-1 human mononuclear cells stimulated by <italic>Streptococcus pneumoniae.</italic></article-title><source>Infect. Immun.</source><volume>71</volume>: <fpage>2087</fpage>–<lpage>2094</lpage><pub-id pub-id-type="pmid">12654830</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
